,drug_name,target
97,pravastatin,Histone deacetylase 2 inhibitor
98,fluvoxamine,Sodium-dependent serotonin transporter inhibitor
99,fluvoxamine,Potassium voltage-gated channel subfamily H member 2 inhibitor
100,valsartan,Type-1 angiotensin II receptor antagonist
101,ramipril,Angiotensin-converting enzyme inhibitor
103,flunisolide,Glucocorticoid receptor agonist
106,amphetamine,Synaptic vesicular amine transporter inhibitor
109,amphetamine,Sodium-dependent dopamine transporter inhibitor
110,amphetamine,Sodium-dependent dopamine transporter agonist
111,amphetamine,Sodium-dependent dopamine transporter binder
118,amphetamine,Sodium-dependent noradrenaline transporter inhibitor
119,amphetamine,Sodium-dependent noradrenaline transporter agonist
120,amphetamine,Sodium-dependent noradrenaline transporter binder
124,amphetamine,Beta adrenergic receptor inhibitor
127,amphetamine,Dopamine D2 receptor inhibitor
128,amphetamine,Dopamine D2 receptor agonist
129,amphetamine,Dopamine D2 receptor binder
130,amphetamine,Amine oxidase [flavin-containing] B inhibitor
133,amphetamine,Sodium-dependent serotonin transporter inhibitor
134,amphetamine,Sodium-dependent serotonin transporter agonist
135,amphetamine,Sodium-dependent serotonin transporter binder
142,nicotine,Neuronal acetylcholine receptor subunit alpha-4 agonist
143,nicotine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
168,cevimeline,Muscarinic acetylcholine receptor M3 agonist
169,cevimeline,Muscarinic acetylcholine receptor M1 agonist
170,lorazepam,GABA(A) Receptor ligand
171,lorazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
172,esmolol,Beta-1 adrenergic receptor antagonist
176,phentermine,Sodium-dependent noradrenaline transporter inhibitor
177,phentermine,Sodium-dependent noradrenaline transporter antagonist
178,phentermine,Sodium-dependent serotonin transporter inhibitor
179,phentermine,Sodium-dependent serotonin transporter antagonist
180,phentermine,Sodium-dependent dopamine transporter inhibitor
181,phentermine,Sodium-dependent dopamine transporter antagonist
184,phentermine,Amine oxidase [flavin-containing] B inhibitor
188,tramadol,Mu-type opioid receptor agonist
189,tramadol,Mu-type opioid receptor inhibitor
190,tramadol,Mu-type opioid receptor antagonist
192,tramadol,Sodium-dependent noradrenaline transporter agonist
193,tramadol,Sodium-dependent noradrenaline transporter inhibitor
194,tramadol,Sodium-dependent noradrenaline transporter antagonist
196,tramadol,Sodium-dependent serotonin transporter agonist
197,tramadol,Sodium-dependent serotonin transporter inhibitor
198,tramadol,Sodium-dependent serotonin transporter antagonist
200,tramadol,5-hydroxytryptamine receptor 2C agonist
201,tramadol,5-hydroxytryptamine receptor 2C inhibitor
202,tramadol,5-hydroxytryptamine receptor 2C antagonist
204,tramadol,Kappa-type opioid receptor agonist
205,tramadol,Kappa-type opioid receptor inhibitor
206,tramadol,Kappa-type opioid receptor antagonist
208,tramadol,Delta-type opioid receptor agonist
210,tramadol,Delta-type opioid receptor antagonist
216,tramadol,Muscarinic acetylcholine receptor M3 agonist
217,tramadol,Muscarinic acetylcholine receptor M3 inhibitor
218,tramadol,Muscarinic acetylcholine receptor M3 antagonist
220,tramadol,Muscarinic acetylcholine receptor M1 agonist
221,tramadol,Muscarinic acetylcholine receptor M1 inhibitor
222,tramadol,Muscarinic acetylcholine receptor M1 antagonist
241,tramadol,Adenosine receptor A1 inhibitor
242,tramadol,Adenosine receptor A1 antagonist
244,tramadol,Alpha-2 adrenergic receptors agonist
245,tramadol,Alpha-2 adrenergic receptors inhibitor
246,tramadol,Alpha-2 adrenergic receptors antagonist
248,betaxolol,Beta-1 adrenergic receptor antagonist
249,betaxolol,Beta-2 adrenergic receptor antagonist
251,troglitazone,Peroxisome proliferator-activated receptor gamma agonist
252,troglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
272,troglitazone,Peroxisome proliferator-activated receptor alpha agonist
273,troglitazone,Peroxisome proliferator-activated receptor alpha inhibitor
285,erythromycin,Potassium voltage-gated channel subfamily H member 2 inhibitor
294,caffeine,Adenosine receptor A1 antagonist
295,caffeine,Adenosine receptor A1 inhibitor
324,succinylcholine,Muscarinic acetylcholine receptor M3 agonist
325,sildenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
328,dofetilide,Potassium voltage-gated channel subfamily H member 2 inhibitor
331,reserpine,Synaptic vesicular amine transporter inhibitor
336,trospium,Muscarinic acetylcholine receptor M1 antagonist
337,trospium,Muscarinic acetylcholine receptor M3 antagonist
338,midodrine,Alpha-1A adrenergic receptor agonist
339,midodrine,Alpha-1B adrenergic receptor agonist
340,midodrine,Alpha-1D adrenergic receptor agonist
345,citalopram,Sodium-dependent serotonin transporter inhibitor
346,citalopram,Sodium-dependent serotonin transporter binder
347,citalopram,Histamine H1 receptor inhibitor
348,citalopram,Histamine H1 receptor binder
349,eletriptan,5-hydroxytryptamine receptor 1D agonist
350,eletriptan,5-hydroxytryptamine receptor 1B agonist
351,eletriptan,5-hydroxytryptamine receptor 1F agonist
352,eletriptan,5-hydroxytryptamine receptor 1A agonist
353,moxifloxacin,DNA topoisomerase 4 subunit A inhibitor
354,moxifloxacin,DNA gyrase subunit A inhibitor
355,moxifloxacin,DNA topoisomerase 2-alpha inhibitor
363,indinavir,Human immunodeficiency virus type 1 protease inhibitor
364,temazepam,GABA(A) Receptor ligand
365,temazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
366,reboxetine,Sodium-dependent noradrenaline transporter inhibitor
367,milrinone,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
368,butabarbital,GABA(A) Receptor inhibitor
369,butabarbital,GABA(A) Receptor antagonist
399,cladribine,DNA inhibitor
429,ranolazine,Alpha-1 adrenergic receptors inhibitor
430,ranolazine,Alpha-1 adrenergic receptors antagonist
432,ranolazine,Beta-1 adrenergic receptor inhibitor
433,ranolazine,Beta-1 adrenergic receptor antagonist
438,ziprasidone,Dopamine D2 receptor antagonist
439,ziprasidone,Dopamine D2 receptor agonist
440,ziprasidone,Dopamine D1 receptor antagonist
441,ziprasidone,Dopamine D1 receptor agonist
442,ziprasidone,Dopamine D5 receptor antagonist
443,ziprasidone,Dopamine D5 receptor agonist
444,ziprasidone,5-hydroxytryptamine receptor 2A antagonist
445,ziprasidone,5-hydroxytryptamine receptor 2A agonist
446,ziprasidone,Dopamine D3 receptor antagonist
447,ziprasidone,Dopamine D3 receptor agonist
448,ziprasidone,Dopamine D4 receptor antagonist
449,ziprasidone,Dopamine D4 receptor agonist
450,ziprasidone,5-hydroxytryptamine receptor 1A antagonist
451,ziprasidone,5-hydroxytryptamine receptor 1A agonist
452,ziprasidone,5-hydroxytryptamine receptor 1B antagonist
453,ziprasidone,5-hydroxytryptamine receptor 1B agonist
454,ziprasidone,5-hydroxytryptamine receptor 1D antagonist
455,ziprasidone,5-hydroxytryptamine receptor 1D agonist
456,ziprasidone,5-hydroxytryptamine receptor 1E antagonist
458,ziprasidone,5-hydroxytryptamine receptor 2C antagonist
459,ziprasidone,5-hydroxytryptamine receptor 2C agonist
460,ziprasidone,5-hydroxytryptamine receptor 6 antagonist
462,ziprasidone,5-hydroxytryptamine receptor 7 antagonist
463,ziprasidone,5-hydroxytryptamine receptor 7 agonist
464,ziprasidone,Histamine H1 receptor antagonist
465,ziprasidone,Histamine H1 receptor agonist
466,ziprasidone,Alpha-1A adrenergic receptor antagonist
467,ziprasidone,Alpha-1A adrenergic receptor agonist
468,ziprasidone,Alpha-1B adrenergic receptor antagonist
469,ziprasidone,Alpha-1B adrenergic receptor agonist
470,ziprasidone,Alpha-2A adrenergic receptor antagonist
471,ziprasidone,Alpha-2A adrenergic receptor agonist
472,ziprasidone,Alpha-2B adrenergic receptor antagonist
473,ziprasidone,Alpha-2B adrenergic receptor agonist
474,ziprasidone,Alpha-2C adrenergic receptor antagonist
475,ziprasidone,Alpha-2C adrenergic receptor agonist
476,ziprasidone,Muscarinic acetylcholine receptor M1 antagonist
477,ziprasidone,Muscarinic acetylcholine receptor M1 agonist
478,ziprasidone,Muscarinic acetylcholine receptor M2 antagonist
480,ziprasidone,Muscarinic acetylcholine receptor M3 antagonist
481,ziprasidone,Muscarinic acetylcholine receptor M3 agonist
482,ziprasidone,Muscarinic acetylcholine receptor M4 antagonist
484,ziprasidone,Muscarinic acetylcholine receptor M5 antagonist
490,methysergide,5-hydroxytryptamine receptor 2B antagonist
491,methysergide,5-hydroxytryptamine receptor 2B agonist
492,methysergide,5-hydroxytryptamine receptor 2B binder
493,methysergide,5-hydroxytryptamine receptor 2C antagonist
494,methysergide,5-hydroxytryptamine receptor 2C agonist
495,methysergide,5-hydroxytryptamine receptor 2C binder
496,methysergide,5-hydroxytryptamine receptor 2A antagonist
497,methysergide,5-hydroxytryptamine receptor 2A agonist
498,methysergide,5-hydroxytryptamine receptor 2A binder
499,methysergide,5-hydroxytryptamine receptor 1A antagonist
500,methysergide,5-hydroxytryptamine receptor 1A agonist
501,methysergide,5-hydroxytryptamine receptor 1A binder
502,methysergide,5-hydroxytryptamine receptor 7 antagonist
503,methysergide,5-hydroxytryptamine receptor 7 agonist
504,methysergide,5-hydroxytryptamine receptor 7 binder
505,methysergide,5-hydroxytryptamine receptor 1B antagonist
506,methysergide,5-hydroxytryptamine receptor 1B agonist
509,methysergide,5-hydroxytryptamine receptor 1F agonist
511,methysergide,5-hydroxytryptamine receptor 1E antagonist
514,cabergoline,Dopamine D2 receptor agonist
515,cabergoline,Dopamine D2 receptor antagonist
516,cabergoline,Dopamine D2 receptor binder
517,cabergoline,5-hydroxytryptamine receptor 2B agonist
518,cabergoline,5-hydroxytryptamine receptor 2B antagonist
519,cabergoline,5-hydroxytryptamine receptor 2B binder
520,cabergoline,Dopamine D3 receptor agonist
521,cabergoline,Dopamine D3 receptor antagonist
522,cabergoline,Dopamine D3 receptor binder
523,cabergoline,5-hydroxytryptamine receptor 2A agonist
524,cabergoline,5-hydroxytryptamine receptor 2A antagonist
525,cabergoline,5-hydroxytryptamine receptor 2A binder
526,cabergoline,Alpha-2B adrenergic receptor agonist
527,cabergoline,Alpha-2B adrenergic receptor antagonist
528,cabergoline,Alpha-2B adrenergic receptor binder
529,cabergoline,5-hydroxytryptamine receptor 1D agonist
530,cabergoline,5-hydroxytryptamine receptor 1D antagonist
532,cabergoline,Dopamine D4 receptor agonist
533,cabergoline,Dopamine D4 receptor antagonist
535,cabergoline,Alpha-2A adrenergic receptor agonist
536,cabergoline,Alpha-2A adrenergic receptor antagonist
537,cabergoline,Alpha-2A adrenergic receptor binder
538,cabergoline,5-hydroxytryptamine receptor 1A agonist
539,cabergoline,5-hydroxytryptamine receptor 1A antagonist
540,cabergoline,5-hydroxytryptamine receptor 1A binder
541,cabergoline,Alpha-2C adrenergic receptor agonist
542,cabergoline,Alpha-2C adrenergic receptor antagonist
544,cabergoline,Dopamine D5 receptor agonist
545,cabergoline,Dopamine D5 receptor antagonist
547,cabergoline,Dopamine D1 receptor agonist
548,cabergoline,Dopamine D1 receptor antagonist
550,cabergoline,5-hydroxytryptamine receptor 1B agonist
551,cabergoline,5-hydroxytryptamine receptor 1B antagonist
553,cabergoline,5-hydroxytryptamine receptor 2C agonist
554,cabergoline,5-hydroxytryptamine receptor 2C antagonist
555,cabergoline,5-hydroxytryptamine receptor 2C binder
556,cabergoline,5-hydroxytryptamine receptor 7 agonist
557,cabergoline,5-hydroxytryptamine receptor 7 antagonist
558,cabergoline,5-hydroxytryptamine receptor 7 binder
559,cabergoline,Alpha-1A adrenergic receptor agonist
560,cabergoline,Alpha-1A adrenergic receptor antagonist
561,cabergoline,Alpha-1A adrenergic receptor binder
562,cabergoline,Alpha-1B adrenergic receptor agonist
563,cabergoline,Alpha-1B adrenergic receptor antagonist
564,cabergoline,Alpha-1B adrenergic receptor binder
565,cabergoline,Alpha-1D adrenergic receptor agonist
566,cabergoline,Alpha-1D adrenergic receptor antagonist
567,cabergoline,Alpha-1D adrenergic receptor binder
568,cabergoline,Beta-1 adrenergic receptor agonist
569,cabergoline,Beta-1 adrenergic receptor antagonist
571,cabergoline,Beta-2 adrenergic receptor agonist
572,cabergoline,Beta-2 adrenergic receptor antagonist
574,cabergoline,D(1) dopamine receptor agonist
575,cabergoline,D(1) dopamine receptor antagonist
576,cabergoline,D(1) dopamine receptor binder
579,phenytoin,Sodium channel protein type 5 subunit alpha inhibitor
581,phenytoin,Nuclear receptor subfamily 1 group I member 2 inhibitor
584,phenytoin,Potassium voltage-gated channel subfamily H member 2 inhibitor
588,phenytoin,GABA(A) Receptor inhibitor
590,anagrelide,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
591,metoprolol,Beta-1 adrenergic receptor antagonist
592,metoprolol,Beta-2 adrenergic receptor antagonist
593,ropinirole,Dopamine D3 receptor agonist
594,ropinirole,Dopamine D3 receptor antagonist
595,ropinirole,Dopamine D4 receptor agonist
596,ropinirole,Dopamine D4 receptor antagonist
599,ropinirole,Dopamine D2 receptor agonist
600,ropinirole,Dopamine D2 receptor antagonist
601,isradipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
602,isradipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
603,isradipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
606,isradipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
607,isradipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
608,topiramate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
610,topiramate,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
618,topiramate,Carbonic anhydrase 2 inhibitor
624,topiramate,Carbonic anhydrase 1 inhibitor
627,topiramate,Carbonic anhydrase 3 inhibitor
635,olmesartan,Type-1 angiotensin II receptor antagonist
636,amsacrine,DNA inhibitor
637,amsacrine,DNA topoisomerase 2-alpha inhibitor
638,amsacrine,Potassium voltage-gated channel subfamily H member 2 inhibitor
641,theophylline,Adenosine receptor A1 antagonist
642,theophylline,Adenosine receptor A1 inhibitor
654,theophylline,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
660,theophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
663,theophylline,Histone deacetylase 2 inhibitor
684,disopyramide,Sodium channel protein type 5 subunit alpha inhibitor
686,disopyramide,Muscarinic acetylcholine receptor M1 inhibitor
687,disopyramide,Muscarinic acetylcholine receptor M1 antagonist
688,disopyramide,Muscarinic acetylcholine receptor M2 inhibitor
689,disopyramide,Muscarinic acetylcholine receptor M2 antagonist
690,disopyramide,Muscarinic acetylcholine receptor M3 inhibitor
691,disopyramide,Muscarinic acetylcholine receptor M3 antagonist
696,disopyramide,Potassium voltage-gated channel subfamily H member 2 inhibitor
697,disopyramide,Potassium voltage-gated channel subfamily H member 2 antagonist
700,lidocaine,Sodium channel protein type 10 subunit alpha inhibitor
704,lidocaine,Sodium channel protein type 5 subunit alpha inhibitor
714,clemastine,Histamine H1 receptor antagonist
715,venlafaxine,Sodium-dependent serotonin transporter inhibitor
716,venlafaxine,Sodium-dependent noradrenaline transporter inhibitor
717,venlafaxine,Sodium-dependent dopamine transporter inhibitor
719,atomoxetine,Sodium-dependent noradrenaline transporter inhibitor
720,atomoxetine,Sodium-dependent noradrenaline transporter binder
722,atomoxetine,Sodium-dependent serotonin transporter inhibitor
723,atomoxetine,Sodium-dependent serotonin transporter binder
731,atomoxetine,Kappa-type opioid receptor inhibitor
732,atomoxetine,Kappa-type opioid receptor binder
733,atomoxetine,Kappa-type opioid receptor partial agonist
735,bleomycin,DNA inhibitor
737,etomidate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
738,etomidate,Alpha-2B adrenergic receptor agonist
739,etomidate,GABA(A) Receptor agonist
740,raltitrexed,Thymidylate synthase inhibitor
744,morphine,Mu-type opioid receptor agonist
746,morphine,Kappa-type opioid receptor agonist
748,morphine,Delta-type opioid receptor agonist
752,ropivacaine,Sodium channel protein type 10 subunit alpha inhibitor
753,bupivacaine,Sodium channel protein type 10 subunit alpha inhibitor
757,penciclovir,DNA polymerase catalytic subunit inhibitor
773,ibutilide,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
777,ibutilide,Potassium voltage-gated channel subfamily H member 2 inhibitor
779,ibutilide,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
792,pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
793,pentobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
811,pentobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
814,pentobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
823,pentobarbital,GABA(A) Receptor antagonist
831,zolmitriptan,5-hydroxytryptamine receptor 1B agonist
832,zolmitriptan,5-hydroxytryptamine receptor 1D agonist
833,zolmitriptan,5-hydroxytryptamine receptor 1F agonist
835,zolmitriptan,5-hydroxytryptamine receptor 7 agonist
836,zolmitriptan,5-hydroxytryptamine receptor 1A agonist
837,zolmitriptan,5-hydroxytryptamine receptor 2A agonist
838,zolmitriptan,5-hydroxytryptamine receptor 2B agonist
841,acetaminophen,Prostaglandin G/H synthase 2 inhibitor
843,acetaminophen,Prostaglandin G/H synthase 1 inhibitor
848,codeine,Mu-type opioid receptor agonist
849,codeine,Kappa-type opioid receptor agonist
850,codeine,Delta-type opioid receptor agonist
851,dihydroergotamine,5-hydroxytryptamine receptor 1B agonist
852,dihydroergotamine,5-hydroxytryptamine receptor 1D agonist
853,dihydroergotamine,5-hydroxytryptamine receptor 1F agonist
854,dihydroergotamine,Alpha-2A adrenergic receptor agonist
855,dihydroergotamine,5-hydroxytryptamine receptor 1A agonist
857,dihydroergotamine,5-hydroxytryptamine receptor 2A agonist
858,dihydroergotamine,5-hydroxytryptamine receptor 2B agonist
859,dihydroergotamine,5-hydroxytryptamine receptor 2C agonist
860,dihydroergotamine,Alpha-1 adrenergic receptors agonist
861,dihydroergotamine,Alpha-2 adrenergic receptors agonist
862,dihydroergotamine,Dopamine D2 receptor agonist
863,dihydroergotamine,Dopamine D3 receptor agonist
864,dihydroergotamine,Dopamine D4 receptor agonist
866,dihydroergotamine,Beta-3 adrenergic receptor agonist
867,amitriptyline,Sodium-dependent noradrenaline transporter inhibitor
868,amitriptyline,Sodium-dependent noradrenaline transporter antagonist
870,amitriptyline,Sodium-dependent noradrenaline transporter agonist
872,amitriptyline,Sodium-dependent noradrenaline transporter binder
874,amitriptyline,Sodium-dependent serotonin transporter inhibitor
875,amitriptyline,Sodium-dependent serotonin transporter antagonist
877,amitriptyline,Sodium-dependent serotonin transporter agonist
879,amitriptyline,Sodium-dependent serotonin transporter binder
881,amitriptyline,5-hydroxytryptamine receptor 2A inhibitor
882,amitriptyline,5-hydroxytryptamine receptor 2A antagonist
884,amitriptyline,5-hydroxytryptamine receptor 2A agonist
886,amitriptyline,5-hydroxytryptamine receptor 2A binder
888,amitriptyline,5-hydroxytryptamine receptor 1A inhibitor
889,amitriptyline,5-hydroxytryptamine receptor 1A antagonist
891,amitriptyline,5-hydroxytryptamine receptor 1A agonist
893,amitriptyline,5-hydroxytryptamine receptor 1A binder
896,amitriptyline,Delta-type opioid receptor antagonist
898,amitriptyline,Delta-type opioid receptor agonist
902,amitriptyline,Kappa-type opioid receptor inhibitor
903,amitriptyline,Kappa-type opioid receptor antagonist
905,amitriptyline,Kappa-type opioid receptor agonist
907,amitriptyline,Kappa-type opioid receptor binder
923,amitriptyline,Alpha-1A adrenergic receptor inhibitor
924,amitriptyline,Alpha-1A adrenergic receptor antagonist
926,amitriptyline,Alpha-1A adrenergic receptor agonist
928,amitriptyline,Alpha-1A adrenergic receptor binder
930,amitriptyline,Alpha-1D adrenergic receptor inhibitor
931,amitriptyline,Alpha-1D adrenergic receptor antagonist
933,amitriptyline,Alpha-1D adrenergic receptor agonist
935,amitriptyline,Alpha-1D adrenergic receptor binder
937,amitriptyline,Alpha-2A adrenergic receptor inhibitor
938,amitriptyline,Alpha-2A adrenergic receptor antagonist
940,amitriptyline,Alpha-2A adrenergic receptor agonist
942,amitriptyline,Alpha-2A adrenergic receptor binder
944,amitriptyline,Histamine H1 receptor inhibitor
945,amitriptyline,Histamine H1 receptor antagonist
947,amitriptyline,Histamine H1 receptor agonist
949,amitriptyline,Histamine H1 receptor binder
966,amitriptyline,Histamine H2 receptor antagonist
973,amitriptyline,Histamine H4 receptor antagonist
977,amitriptyline,Histamine H4 receptor binder
986,amitriptyline,5-hydroxytryptamine receptor 2C inhibitor
987,amitriptyline,5-hydroxytryptamine receptor 2C antagonist
989,amitriptyline,5-hydroxytryptamine receptor 2C agonist
991,amitriptyline,5-hydroxytryptamine receptor 2C binder
993,amitriptyline,Alpha-1B adrenergic receptor inhibitor
994,amitriptyline,Alpha-1B adrenergic receptor antagonist
996,amitriptyline,Alpha-1B adrenergic receptor agonist
998,amitriptyline,Alpha-1B adrenergic receptor binder
1000,amitriptyline,5-hydroxytryptamine receptor 7 inhibitor
1001,amitriptyline,5-hydroxytryptamine receptor 7 antagonist
1003,amitriptyline,5-hydroxytryptamine receptor 7 agonist
1005,amitriptyline,5-hydroxytryptamine receptor 7 binder
1008,amitriptyline,5-hydroxytryptamine receptor 1D antagonist
1010,amitriptyline,5-hydroxytryptamine receptor 1D agonist
1014,amitriptyline,Mu-type opioid receptor inhibitor
1015,amitriptyline,Mu-type opioid receptor antagonist
1017,amitriptyline,Mu-type opioid receptor agonist
1022,amitriptyline,5-hydroxytryptamine receptor 1B antagonist
1024,amitriptyline,5-hydroxytryptamine receptor 1B agonist
1028,amitriptyline,5-hydroxytryptamine receptor 6 inhibitor
1029,amitriptyline,5-hydroxytryptamine receptor 6 antagonist
1033,amitriptyline,5-hydroxytryptamine receptor 6 binder
1049,amitriptyline,Muscarinic acetylcholine receptor inhibitor
1050,amitriptyline,Muscarinic acetylcholine receptor antagonist
1054,amitriptyline,Muscarinic acetylcholine receptor binder
1065,hydromorphone,Mu-type opioid receptor agonist
1067,hydromorphone,Delta-type opioid receptor agonist
1069,hydromorphone,Kappa-type opioid receptor agonist
1070,hydromorphone,Kappa-type opioid receptor partial agonist
1071,indomethacin,Prostaglandin G/H synthase 1 inhibitor
1076,indomethacin,Prostaglandin G/H synthase 2 inhibitor
1091,indomethacin,Peroxisome proliferator-activated receptor gamma inhibitor
1094,indomethacin,Peroxisome proliferator-activated receptor gamma agonist
1106,indomethacin,Peroxisome proliferator-activated receptor alpha inhibitor
1109,indomethacin,Peroxisome proliferator-activated receptor alpha agonist
1133,ipratropium,Muscarinic acetylcholine receptor M1 antagonist
1134,ipratropium,Muscarinic acetylcholine receptor M2 antagonist
1135,ipratropium,Muscarinic acetylcholine receptor M3 antagonist
1136,methadone,Mu-type opioid receptor agonist
1137,methadone,Mu-type opioid receptor antagonist
1140,methadone,Delta-type opioid receptor agonist
1141,methadone,Delta-type opioid receptor antagonist
1142,methadone,5-hydroxytryptamine receptor 3A agonist
1143,methadone,5-hydroxytryptamine receptor 3A antagonist
1145,methadone,Neuronal acetylcholine receptor subunit alpha-7 antagonist
1148,methadone,Neuronal acetylcholine receptor subunit alpha-4 agonist
1149,methadone,Neuronal acetylcholine receptor subunit alpha-4 antagonist
1152,olanzapine,5-hydroxytryptamine receptor 2A antagonist
1153,olanzapine,5-hydroxytryptamine receptor 2A inhibitor
1154,olanzapine,Dopamine D2 receptor antagonist
1155,olanzapine,Dopamine D2 receptor inhibitor
1156,olanzapine,Dopamine D1 receptor antagonist
1157,olanzapine,Dopamine D1 receptor inhibitor
1158,olanzapine,Dopamine D5 receptor antagonist
1160,olanzapine,Dopamine D3 receptor antagonist
1161,olanzapine,Dopamine D3 receptor inhibitor
1162,olanzapine,Dopamine D4 receptor antagonist
1164,olanzapine,5-hydroxytryptamine receptor 2C antagonist
1165,olanzapine,5-hydroxytryptamine receptor 2C inhibitor
1166,olanzapine,5-hydroxytryptamine receptor 3A antagonist
1167,olanzapine,5-hydroxytryptamine receptor 3A inhibitor
1168,olanzapine,5-hydroxytryptamine receptor 6 antagonist
1169,olanzapine,5-hydroxytryptamine receptor 6 inhibitor
1170,olanzapine,Histamine H1 receptor antagonist
1171,olanzapine,Histamine H1 receptor inhibitor
1172,olanzapine,Alpha-1A adrenergic receptor antagonist
1173,olanzapine,Alpha-1A adrenergic receptor inhibitor
1174,olanzapine,Alpha-1B adrenergic receptor antagonist
1175,olanzapine,Alpha-1B adrenergic receptor inhibitor
1176,olanzapine,Muscarinic acetylcholine receptor M1 antagonist
1177,olanzapine,Muscarinic acetylcholine receptor M1 inhibitor
1178,olanzapine,Muscarinic acetylcholine receptor M2 antagonist
1179,olanzapine,Muscarinic acetylcholine receptor M2 inhibitor
1180,olanzapine,Muscarinic acetylcholine receptor M3 antagonist
1181,olanzapine,Muscarinic acetylcholine receptor M3 inhibitor
1182,olanzapine,Muscarinic acetylcholine receptor M4 antagonist
1183,olanzapine,Muscarinic acetylcholine receptor M4 inhibitor
1184,olanzapine,D(1) dopamine receptor antagonist
1185,olanzapine,D(1) dopamine receptor inhibitor
1187,olanzapine,Beta adrenergic receptor inhibitor
1192,atenolol,Beta-1 adrenergic receptor antagonist
1193,atenolol,Beta-2 adrenergic receptor antagonist
1198,cetirizine,Histamine H1 receptor antagonist
1199,protriptyline,Sodium-dependent noradrenaline transporter inhibitor
1200,protriptyline,Sodium-dependent serotonin transporter inhibitor
1201,alfuzosin,Alpha-1A adrenergic receptor antagonist
1202,alfuzosin,Alpha-1B adrenergic receptor antagonist
1203,alfuzosin,Alpha-1D adrenergic receptor antagonist
1204,alfuzosin,Alpha-1 adrenergic receptors antagonist
1208,methylergometrine,Dopamine D1 receptor antagonist
1209,methylergometrine,5-hydroxytryptamine receptor 2B antagonist
1222,clozapine,Dopamine D2 receptor antagonist
1223,clozapine,5-hydroxytryptamine receptor 2A antagonist
1224,clozapine,Dopamine D1 receptor antagonist
1225,clozapine,Dopamine D3 receptor antagonist
1226,clozapine,Dopamine D4 receptor antagonist
1227,clozapine,5-hydroxytryptamine receptor 1A antagonist
1228,clozapine,5-hydroxytryptamine receptor 1B antagonist
1229,clozapine,5-hydroxytryptamine receptor 1D antagonist
1230,clozapine,5-hydroxytryptamine receptor 1E antagonist
1231,clozapine,5-hydroxytryptamine receptor 3A antagonist
1232,clozapine,5-hydroxytryptamine receptor 2C antagonist
1233,clozapine,5-hydroxytryptamine receptor 6 antagonist
1234,clozapine,5-hydroxytryptamine receptor 7 antagonist
1235,clozapine,Histamine H1 receptor antagonist
1236,clozapine,Histamine H4 receptor antagonist
1237,clozapine,Alpha-1A adrenergic receptor antagonist
1238,clozapine,Alpha-1B adrenergic receptor antagonist
1239,clozapine,Alpha-2A adrenergic receptor antagonist
1240,clozapine,Alpha-2B adrenergic receptor antagonist
1241,clozapine,Alpha-2C adrenergic receptor antagonist
1242,clozapine,Muscarinic acetylcholine receptor M1 antagonist
1243,clozapine,Muscarinic acetylcholine receptor M2 antagonist
1244,clozapine,Muscarinic acetylcholine receptor M3 antagonist
1245,clozapine,Muscarinic acetylcholine receptor M4 antagonist
1246,clozapine,Muscarinic acetylcholine receptor M5 antagonist
1255,levonorgestrel,Estrogen receptor alpha inhibitor
1258,levonorgestrel,Androgen receptor inhibitor
1267,norepinephrine,Alpha-1A adrenergic receptor agonist
1268,norepinephrine,Alpha-1A adrenergic receptor inhibitor
1269,norepinephrine,Alpha-1A adrenergic receptor binder
1270,norepinephrine,Alpha-1B adrenergic receptor agonist
1271,norepinephrine,Alpha-1B adrenergic receptor inhibitor
1272,norepinephrine,Alpha-1B adrenergic receptor binder
1273,norepinephrine,Alpha-1D adrenergic receptor agonist
1274,norepinephrine,Alpha-1D adrenergic receptor inhibitor
1275,norepinephrine,Alpha-1D adrenergic receptor binder
1276,norepinephrine,Alpha-2A adrenergic receptor agonist
1277,norepinephrine,Alpha-2A adrenergic receptor inhibitor
1278,norepinephrine,Alpha-2A adrenergic receptor binder
1279,norepinephrine,Alpha-2B adrenergic receptor agonist
1280,norepinephrine,Alpha-2B adrenergic receptor inhibitor
1281,norepinephrine,Alpha-2B adrenergic receptor binder
1282,norepinephrine,Alpha-2C adrenergic receptor agonist
1283,norepinephrine,Alpha-2C adrenergic receptor inhibitor
1285,norepinephrine,Beta-1 adrenergic receptor agonist
1286,norepinephrine,Beta-1 adrenergic receptor inhibitor
1288,norepinephrine,Beta-2 adrenergic receptor agonist
1289,norepinephrine,Beta-2 adrenergic receptor inhibitor
1291,norepinephrine,Beta-3 adrenergic receptor agonist
1298,norepinephrine,Synaptic vesicular amine transporter inhibitor
1303,cidofovir,DNA polymerase catalytic subunit inhibitor
1304,mirtazapine,5-hydroxytryptamine receptor 2A antagonist
1305,mirtazapine,5-hydroxytryptamine receptor 2A agonist
1308,mirtazapine,Alpha-2A adrenergic receptor antagonist
1309,mirtazapine,Alpha-2A adrenergic receptor agonist
1310,mirtazapine,5-hydroxytryptamine receptor 2C antagonist
1311,mirtazapine,5-hydroxytryptamine receptor 2C agonist
1312,mirtazapine,Kappa-type opioid receptor antagonist
1313,mirtazapine,Kappa-type opioid receptor agonist
1314,mirtazapine,Histamine H1 receptor antagonist
1315,mirtazapine,Histamine H1 receptor agonist
1316,mirtazapine,Alpha-1 adrenergic receptors antagonist
1317,mirtazapine,Alpha-1 adrenergic receptors agonist
1318,meprobamate,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
1324,meprobamate,GABA(A) Receptor agonist
1325,timolol,Beta-1 adrenergic receptor antagonist
1326,timolol,Beta-2 adrenergic receptor antagonist
1332,trihexyphenidyl,Muscarinic acetylcholine receptor M1 antagonist
1333,trihexyphenidyl,Muscarinic acetylcholine receptor M2 antagonist
1334,trihexyphenidyl,Muscarinic acetylcholine receptor M3 antagonist
1335,trihexyphenidyl,Muscarinic acetylcholine receptor M4 antagonist
1336,trihexyphenidyl,Muscarinic acetylcholine receptor M5 antagonist
1337,palonosetron,5-hydroxytryptamine receptor 3A antagonist
1338,mexiletine,Sodium channel protein type 5 subunit alpha inhibitor
1342,dexrazoxane,DNA topoisomerase 2-alpha inhibitor
1344,amlodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
1348,amlodipine,Carbonic anhydrase 1 inhibitor
1352,phenylephrine,Alpha-1A adrenergic receptor agonist
1353,phenylephrine,Alpha-1B adrenergic receptor agonist
1354,phenylephrine,Alpha-1D adrenergic receptor agonist
1356,nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
1359,nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
1365,nimodipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
1371,nimodipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
1398,progesterone,Estrogen receptor alpha agonist
1399,progesterone,Estrogen receptor alpha inhibitor
1400,progesterone,Estrogen receptor alpha antagonist
1419,progesterone,Kappa-type opioid receptor agonist
1420,progesterone,Kappa-type opioid receptor inhibitor
1421,progesterone,Kappa-type opioid receptor antagonist
1424,progesterone,Kappa-type opioid receptor binder
1425,progesterone,Kappa-type opioid receptor partial agonist
1433,progesterone,Glucocorticoid receptor agonist
1440,progesterone,Androgen receptor agonist
1441,progesterone,Androgen receptor inhibitor
1442,progesterone,Androgen receptor antagonist
1454,progesterone,Estrogen receptor beta agonist
1462,phenylpropanolamine,Dopamine D1 receptor agonist
1463,phenylpropanolamine,Beta-1 adrenergic receptor partial agonist
1464,phenylpropanolamine,Beta-1 adrenergic receptor agonist
1465,phenylpropanolamine,Beta-2 adrenergic receptor partial agonist
1466,phenylpropanolamine,Beta-2 adrenergic receptor agonist
1468,phenylpropanolamine,Alpha-2 adrenergic receptors agonist
1475,sorafenib,Vascular endothelial growth factor receptor 2 inhibitor
1479,sorafenib,Platelet-derived growth factor receptor beta inhibitor
1481,sorafenib,Mast/stem cell growth factor receptor Kit inhibitor
1489,nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
1490,nisoldipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
1491,nisoldipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
1492,nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
1493,nisoldipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
1494,alprazolam,GABA(A) Receptor ligand
1495,alprazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
1496,loxapine,Dopamine D2 receptor antagonist
1497,loxapine,Dopamine D2 receptor binder
1498,loxapine,Dopamine D1 receptor antagonist
1500,loxapine,5-hydroxytryptamine receptor 2A antagonist
1501,loxapine,5-hydroxytryptamine receptor 2A binder
1502,loxapine,5-hydroxytryptamine receptor 2C antagonist
1503,loxapine,5-hydroxytryptamine receptor 2C binder
1504,loxapine,5-hydroxytryptamine receptor 1A antagonist
1505,loxapine,5-hydroxytryptamine receptor 1A binder
1506,loxapine,5-hydroxytryptamine receptor 1B antagonist
1508,loxapine,5-hydroxytryptamine receptor 1D antagonist
1510,loxapine,5-hydroxytryptamine receptor 1E antagonist
1512,loxapine,5-hydroxytryptamine receptor 3A antagonist
1513,loxapine,5-hydroxytryptamine receptor 3A binder
1516,loxapine,5-hydroxytryptamine receptor 6 antagonist
1517,loxapine,5-hydroxytryptamine receptor 6 binder
1518,loxapine,5-hydroxytryptamine receptor 7 antagonist
1519,loxapine,5-hydroxytryptamine receptor 7 binder
1520,loxapine,Alpha-1A adrenergic receptor antagonist
1521,loxapine,Alpha-1A adrenergic receptor binder
1522,loxapine,Alpha-1B adrenergic receptor antagonist
1523,loxapine,Alpha-1B adrenergic receptor binder
1524,loxapine,Alpha-2A adrenergic receptor antagonist
1525,loxapine,Alpha-2A adrenergic receptor binder
1526,loxapine,Alpha-2B adrenergic receptor antagonist
1527,loxapine,Alpha-2B adrenergic receptor binder
1528,loxapine,Alpha-2C adrenergic receptor antagonist
1530,loxapine,Beta-1 adrenergic receptor antagonist
1532,loxapine,Muscarinic acetylcholine receptor M1 antagonist
1533,loxapine,Muscarinic acetylcholine receptor M1 binder
1534,loxapine,Muscarinic acetylcholine receptor M2 antagonist
1536,loxapine,Muscarinic acetylcholine receptor M3 antagonist
1537,loxapine,Muscarinic acetylcholine receptor M3 binder
1538,loxapine,Muscarinic acetylcholine receptor M4 antagonist
1540,loxapine,Muscarinic acetylcholine receptor M5 antagonist
1542,loxapine,D(1) dopamine receptor antagonist
1543,loxapine,D(1) dopamine receptor binder
1544,loxapine,Dopamine D3 receptor antagonist
1545,loxapine,Dopamine D3 receptor binder
1546,loxapine,Dopamine D4 receptor antagonist
1548,loxapine,Dopamine D5 receptor antagonist
1550,loxapine,Histamine H1 receptor antagonist
1551,loxapine,Histamine H1 receptor binder
1552,loxapine,Histamine H2 receptor antagonist
1554,loxapine,Histamine H4 receptor antagonist
1555,loxapine,Histamine H4 receptor binder
1556,loxapine,Sodium-dependent serotonin transporter antagonist
1557,loxapine,Sodium-dependent serotonin transporter binder
1558,loxapine,Sodium-dependent noradrenaline transporter antagonist
1559,loxapine,Sodium-dependent noradrenaline transporter binder
1560,loxapine,Sodium-dependent dopamine transporter antagonist
1561,loxapine,Sodium-dependent dopamine transporter binder
1562,rosiglitazone,Peroxisome proliferator-activated receptor gamma agonist
1563,rosiglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
1566,rosiglitazone,Peroxisome proliferator-activated receptor alpha agonist
1567,rosiglitazone,Peroxisome proliferator-activated receptor alpha inhibitor
1576,pramipexole,Dopamine D3 receptor agonist
1577,pramipexole,Dopamine D2 receptor agonist
1578,pramipexole,Dopamine D4 receptor agonist
1579,pramipexole,5-hydroxytryptamine receptor 1A agonist
1580,pramipexole,Alpha-2A adrenergic receptor agonist
1581,secobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
1582,secobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
1594,secobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
1596,secobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
1603,methylphenidate,Sodium-dependent dopamine transporter inhibitor
1604,methylphenidate,Sodium-dependent noradrenaline transporter inhibitor
1605,methylphenidate,5-hydroxytryptamine receptor 1A inhibitor
1606,methocarbamol,Carbonic anhydrase 1 inhibitor
1607,zolpidem,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
1611,famciclovir,DNA polymerase catalytic subunit inhibitor
1612,prochlorperazine,Dopamine D2 receptor antagonist
1613,prochlorperazine,Histamine H1 receptor antagonist
1614,prochlorperazine,Alpha-1 adrenergic receptors antagonist
1615,prochlorperazine,Alpha-2 adrenergic receptors antagonist
1616,cyproheptadine,Histamine H1 receptor antagonist
1617,cyproheptadine,Histamine H2 receptor antagonist
1618,cyproheptadine,5-hydroxytryptamine receptor 2A antagonist
1619,cyproheptadine,5-hydroxytryptamine receptor 2B antagonist
1620,cyproheptadine,5-hydroxytryptamine receptor 2C antagonist
1621,cyproheptadine,Muscarinic acetylcholine receptor M1 antagonist
1622,cyproheptadine,Muscarinic acetylcholine receptor M2 antagonist
1623,cyproheptadine,Muscarinic acetylcholine receptor M3 antagonist
1624,cyproheptadine,5-hydroxytryptamine receptor 7 antagonist
1630,gemcitabine,DNA inhibitor
1632,gemcitabine,Thymidylate synthase inhibitor
1634,teniposide,DNA topoisomerase 2-alpha inhibitor
1637,dipivefrin,Alpha-1A adrenergic receptor agonist
1638,dipivefrin,Alpha-1A adrenergic receptor inhibitor
1639,dipivefrin,Alpha-2A adrenergic receptor agonist
1640,dipivefrin,Alpha-2A adrenergic receptor inhibitor
1641,dipivefrin,Beta-2 adrenergic receptor agonist
1642,dipivefrin,Beta-2 adrenergic receptor inhibitor
1644,dipivefrin,Cholinesterase inhibitor
1646,dipivefrin,Acetylcholinesterase inhibitor
1647,droperidol,Dopamine D2 receptor antagonist
1648,droperidol,Alpha-1A adrenergic receptor antagonist
1649,meperidine,Kappa-type opioid receptor antagonist
1650,meperidine,Kappa-type opioid receptor binder
1651,meperidine,Kappa-type opioid receptor agonist
1652,meperidine,Kappa-type opioid receptor inhibitor
1673,meperidine,Muscarinic acetylcholine receptor antagonist
1674,meperidine,Muscarinic acetylcholine receptor binder
1676,meperidine,Muscarinic acetylcholine receptor inhibitor
1677,meperidine,Mu-type opioid receptor antagonist
1679,meperidine,Mu-type opioid receptor agonist
1680,meperidine,Mu-type opioid receptor inhibitor
1681,meperidine,Sodium-dependent dopamine transporter antagonist
1682,meperidine,Sodium-dependent dopamine transporter binder
1683,meperidine,Sodium-dependent dopamine transporter agonist
1684,meperidine,Sodium-dependent dopamine transporter inhibitor
1685,meperidine,Sodium-dependent noradrenaline transporter antagonist
1686,meperidine,Sodium-dependent noradrenaline transporter binder
1687,meperidine,Sodium-dependent noradrenaline transporter agonist
1688,meperidine,Sodium-dependent noradrenaline transporter inhibitor
1689,meperidine,Sodium-dependent serotonin transporter antagonist
1690,meperidine,Sodium-dependent serotonin transporter binder
1691,meperidine,Sodium-dependent serotonin transporter agonist
1692,meperidine,Sodium-dependent serotonin transporter inhibitor
1697,loratadine,Histamine H1 receptor antagonist
1698,loratadine,Potassium voltage-gated channel subfamily H member 2 antagonist
1699,prazosin,Alpha-1A adrenergic receptor antagonist
1700,prazosin,Alpha-1A adrenergic receptor inhibitor
1701,prazosin,Alpha-1A adrenergic receptor binder
1702,prazosin,Alpha-1B adrenergic receptor antagonist
1703,prazosin,Alpha-1B adrenergic receptor inhibitor
1704,prazosin,Alpha-1B adrenergic receptor binder
1705,prazosin,Alpha-1D adrenergic receptor antagonist
1706,prazosin,Alpha-1D adrenergic receptor inhibitor
1707,prazosin,Alpha-1D adrenergic receptor binder
1708,prazosin,Potassium voltage-gated channel subfamily H member 2 antagonist
1709,prazosin,Potassium voltage-gated channel subfamily H member 2 inhibitor
1710,prazosin,Potassium voltage-gated channel subfamily H member 2 binder
1711,prazosin,Alpha-2A adrenergic receptor antagonist
1712,prazosin,Alpha-2A adrenergic receptor inhibitor
1713,prazosin,Alpha-2A adrenergic receptor binder
1714,prazosin,Alpha-2B adrenergic receptor antagonist
1715,prazosin,Alpha-2B adrenergic receptor inhibitor
1716,prazosin,Alpha-2B adrenergic receptor binder
1717,prazosin,Alpha-1 adrenergic receptors antagonist
1718,prazosin,Alpha-1 adrenergic receptors inhibitor
1719,prazosin,Alpha-1 adrenergic receptors binder
1720,imipramine,Sodium-dependent noradrenaline transporter inhibitor
1721,imipramine,Sodium-dependent noradrenaline transporter antagonist
1722,imipramine,Sodium-dependent noradrenaline transporter binder
1724,imipramine,5-hydroxytryptamine receptor 2A inhibitor
1725,imipramine,5-hydroxytryptamine receptor 2A antagonist
1726,imipramine,5-hydroxytryptamine receptor 2A binder
1728,imipramine,Sodium-dependent serotonin transporter inhibitor
1729,imipramine,Sodium-dependent serotonin transporter antagonist
1730,imipramine,Sodium-dependent serotonin transporter binder
1732,imipramine,Histamine H1 receptor inhibitor
1733,imipramine,Histamine H1 receptor antagonist
1734,imipramine,Histamine H1 receptor binder
1736,imipramine,Alpha-1A adrenergic receptor inhibitor
1737,imipramine,Alpha-1A adrenergic receptor antagonist
1738,imipramine,Alpha-1A adrenergic receptor binder
1740,imipramine,Alpha-1D adrenergic receptor inhibitor
1741,imipramine,Alpha-1D adrenergic receptor antagonist
1742,imipramine,Alpha-1D adrenergic receptor binder
1744,imipramine,Muscarinic acetylcholine receptor M1 inhibitor
1745,imipramine,Muscarinic acetylcholine receptor M1 antagonist
1746,imipramine,Muscarinic acetylcholine receptor M1 binder
1748,imipramine,Muscarinic acetylcholine receptor M2 inhibitor
1749,imipramine,Muscarinic acetylcholine receptor M2 antagonist
1752,imipramine,Muscarinic acetylcholine receptor M3 inhibitor
1753,imipramine,Muscarinic acetylcholine receptor M3 antagonist
1754,imipramine,Muscarinic acetylcholine receptor M3 binder
1756,imipramine,Muscarinic acetylcholine receptor M4 inhibitor
1757,imipramine,Muscarinic acetylcholine receptor M4 antagonist
1760,imipramine,Muscarinic acetylcholine receptor M5 inhibitor
1761,imipramine,Muscarinic acetylcholine receptor M5 antagonist
1772,imipramine,5-hydroxytryptamine receptor 2C inhibitor
1773,imipramine,5-hydroxytryptamine receptor 2C antagonist
1774,imipramine,5-hydroxytryptamine receptor 2C binder
1776,imipramine,Alpha-1B adrenergic receptor inhibitor
1777,imipramine,Alpha-1B adrenergic receptor antagonist
1778,imipramine,Alpha-1B adrenergic receptor binder
1780,imipramine,5-hydroxytryptamine receptor 7 inhibitor
1781,imipramine,5-hydroxytryptamine receptor 7 antagonist
1782,imipramine,5-hydroxytryptamine receptor 7 binder
1784,imipramine,D(1) dopamine receptor inhibitor
1785,imipramine,D(1) dopamine receptor antagonist
1786,imipramine,D(1) dopamine receptor binder
1788,imipramine,Dopamine D2 receptor inhibitor
1789,imipramine,Dopamine D2 receptor antagonist
1790,imipramine,Dopamine D2 receptor binder
1792,imipramine,Potassium voltage-gated channel subfamily H member 2 inhibitor
1793,imipramine,Potassium voltage-gated channel subfamily H member 2 antagonist
1794,imipramine,Potassium voltage-gated channel subfamily H member 2 binder
1796,imipramine,Sodium-dependent dopamine transporter inhibitor
1797,imipramine,Sodium-dependent dopamine transporter antagonist
1798,imipramine,Sodium-dependent dopamine transporter binder
1800,imipramine,5-hydroxytryptamine receptor 1A inhibitor
1801,imipramine,5-hydroxytryptamine receptor 1A antagonist
1802,imipramine,5-hydroxytryptamine receptor 1A binder
1804,imipramine,5-hydroxytryptamine receptor 6 inhibitor
1805,imipramine,5-hydroxytryptamine receptor 6 antagonist
1806,imipramine,5-hydroxytryptamine receptor 6 binder
1824,nabumetone,Prostaglandin G/H synthase 2 inhibitor
1825,nabumetone,Prostaglandin G/H synthase 1 inhibitor
1826,ketorolac,Prostaglandin G/H synthase 2 inhibitor
1827,ketorolac,Prostaglandin G/H synthase 1 inhibitor
1828,tenoxicam,Prostaglandin G/H synthase 2 inhibitor
1829,tenoxicam,Prostaglandin G/H synthase 1 inhibitor
1834,fluoxetine,Sodium-dependent serotonin transporter inhibitor
1835,fluoxetine,Sodium-dependent serotonin transporter antagonist
1836,fluoxetine,5-hydroxytryptamine receptor 2C inhibitor
1837,fluoxetine,5-hydroxytryptamine receptor 2C antagonist
1839,fluoxetine,Neuronal acetylcholine receptor subunit alpha-2 antagonist
1846,fluoxetine,Potassium voltage-gated channel subfamily H member 2 inhibitor
1847,fluoxetine,Potassium voltage-gated channel subfamily H member 2 antagonist
1848,methohexital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
1849,duloxetine,Sodium-dependent serotonin transporter inhibitor
1850,duloxetine,Sodium-dependent noradrenaline transporter inhibitor
1851,duloxetine,Sodium-dependent dopamine transporter inhibitor
1852,chlorpromazine,Dopamine D2 receptor antagonist
1853,chlorpromazine,Dopamine D2 receptor inhibitor
1854,chlorpromazine,Dopamine D2 receptor binder
1855,chlorpromazine,Dopamine D1 receptor antagonist
1856,chlorpromazine,Dopamine D1 receptor inhibitor
1858,chlorpromazine,5-hydroxytryptamine receptor 1A antagonist
1859,chlorpromazine,5-hydroxytryptamine receptor 1A inhibitor
1860,chlorpromazine,5-hydroxytryptamine receptor 1A binder
1861,chlorpromazine,5-hydroxytryptamine receptor 2A antagonist
1862,chlorpromazine,5-hydroxytryptamine receptor 2A inhibitor
1863,chlorpromazine,5-hydroxytryptamine receptor 2A binder
1864,chlorpromazine,Alpha-1A adrenergic receptor antagonist
1865,chlorpromazine,Alpha-1A adrenergic receptor inhibitor
1866,chlorpromazine,Alpha-1A adrenergic receptor binder
1867,chlorpromazine,Alpha-1B adrenergic receptor antagonist
1868,chlorpromazine,Alpha-1B adrenergic receptor inhibitor
1869,chlorpromazine,Alpha-1B adrenergic receptor binder
1870,chlorpromazine,Histamine H1 receptor antagonist
1871,chlorpromazine,Histamine H1 receptor inhibitor
1872,chlorpromazine,Histamine H1 receptor binder
1873,chlorpromazine,Potassium voltage-gated channel subfamily H member 2 antagonist
1874,chlorpromazine,Potassium voltage-gated channel subfamily H member 2 inhibitor
1875,chlorpromazine,Potassium voltage-gated channel subfamily H member 2 binder
1876,chlorpromazine,D(1) dopamine receptor antagonist
1877,chlorpromazine,D(1) dopamine receptor inhibitor
1878,chlorpromazine,D(1) dopamine receptor binder
1879,chlorpromazine,Dopamine D3 receptor antagonist
1880,chlorpromazine,Dopamine D3 receptor inhibitor
1881,chlorpromazine,Dopamine D3 receptor binder
1882,chlorpromazine,Dopamine D4 receptor antagonist
1885,chlorpromazine,Dopamine D5 receptor antagonist
1888,chlorpromazine,5-hydroxytryptamine receptor 2C antagonist
1889,chlorpromazine,5-hydroxytryptamine receptor 2C inhibitor
1890,chlorpromazine,5-hydroxytryptamine receptor 2C binder
1894,chlorpromazine,Alpha-1 adrenergic receptors antagonist
1895,chlorpromazine,Alpha-1 adrenergic receptors inhibitor
1896,chlorpromazine,Alpha-1 adrenergic receptors binder
1897,chlorpromazine,Alpha-2 adrenergic receptors antagonist
1898,chlorpromazine,Alpha-2 adrenergic receptors inhibitor
1899,chlorpromazine,Alpha-2 adrenergic receptors binder
1900,chlorpromazine,Muscarinic acetylcholine receptor M1 antagonist
1901,chlorpromazine,Muscarinic acetylcholine receptor M1 inhibitor
1902,chlorpromazine,Muscarinic acetylcholine receptor M1 binder
1903,chlorpromazine,Muscarinic acetylcholine receptor M3 antagonist
1904,chlorpromazine,Muscarinic acetylcholine receptor M3 inhibitor
1905,chlorpromazine,Muscarinic acetylcholine receptor M3 binder
1909,chlorpromazine,Calmodulin antagonist
1910,chlorpromazine,Calmodulin inhibitor
1915,chlorpromazine,5-hydroxytryptamine receptor 6 antagonist
1916,chlorpromazine,5-hydroxytryptamine receptor 6 inhibitor
1917,chlorpromazine,5-hydroxytryptamine receptor 6 binder
1918,chlorpromazine,5-hydroxytryptamine receptor 7 antagonist
1919,chlorpromazine,5-hydroxytryptamine receptor 7 inhibitor
1920,chlorpromazine,5-hydroxytryptamine receptor 7 binder
1921,chlorpromazine,Histamine H4 receptor antagonist
1923,chlorpromazine,Histamine H4 receptor binder
1931,lenalidomide,Prostaglandin G/H synthase 2 inhibitor
1933,raloxifene,Estrogen receptor alpha agonist
1934,raloxifene,Estrogen receptor beta agonist
1937,celecoxib,Prostaglandin G/H synthase 2 inhibitor
1939,celecoxib,Carbonic anhydrase 2 inhibitor
1940,celecoxib,Carbonic anhydrase 3 inhibitor
1942,brimonidine,Alpha-2A adrenergic receptor agonist
1943,brimonidine,Alpha-2B adrenergic receptor agonist
1944,brimonidine,Alpha-2C adrenergic receptor agonist
1947,sotalol,Potassium voltage-gated channel subfamily H member 2 inhibitor
1948,sotalol,Potassium voltage-gated channel subfamily H member 2 antagonist
1949,sotalol,Beta-1 adrenergic receptor inhibitor
1950,sotalol,Beta-1 adrenergic receptor antagonist
1951,sotalol,Beta-2 adrenergic receptor inhibitor
1952,sotalol,Beta-2 adrenergic receptor antagonist
1953,buspirone,5-hydroxytryptamine receptor 1A partial agonist
1954,buspirone,5-hydroxytryptamine receptor 1A antagonist
1956,buspirone,Dopamine D2 receptor antagonist
1958,buspirone,Dopamine D3 receptor antagonist
1960,buspirone,Dopamine D4 receptor antagonist
1962,buspirone,Alpha-1 adrenergic receptors antagonist
1963,fosinopril,Angiotensin-converting enzyme inhibitor
1965,zidovudine,Reverse transcriptase/RNaseH inhibitor
1967,darifenacin,Muscarinic acetylcholine receptor M3 antagonist
1968,darifenacin,Muscarinic acetylcholine receptor M1 antagonist
1969,darifenacin,Muscarinic acetylcholine receptor M2 antagonist
1970,darifenacin,Muscarinic acetylcholine receptor M4 antagonist
1971,darifenacin,Muscarinic acetylcholine receptor M5 antagonist
1972,oxycodone,Mu-type opioid receptor agonist
1973,oxycodone,Kappa-type opioid receptor agonist
1974,oxycodone,Delta-type opioid receptor agonist
1975,tolmetin,Prostaglandin G/H synthase 2 inhibitor
1976,tolmetin,Prostaglandin G/H synthase 1 inhibitor
1977,cimetidine,Histamine H2 receptor antagonist
1978,haloperidol,Dopamine D2 receptor antagonist
1979,haloperidol,Dopamine D2 receptor other/unknown
1980,haloperidol,Dopamine D1 receptor antagonist
1984,haloperidol,5-hydroxytryptamine receptor 2A antagonist
1985,haloperidol,5-hydroxytryptamine receptor 2A other/unknown
1986,haloperidol,Dopamine D3 receptor antagonist
1992,haloperidol,5-hydroxytryptamine receptor 2C antagonist
1996,haloperidol,Histamine H1 receptor antagonist
1998,haloperidol,Muscarinic acetylcholine receptor M3 antagonist
2000,haloperidol,Alpha-1A adrenergic receptor antagonist
2002,haloperidol,Alpha-2A adrenergic receptor antagonist
2004,haloperidol,Alpha-2B adrenergic receptor antagonist
2006,haloperidol,Alpha-2C adrenergic receptor antagonist
2008,haloperidol,5-hydroxytryptamine receptor 1A antagonist
2009,haloperidol,5-hydroxytryptamine receptor 1A other/unknown
2010,haloperidol,5-hydroxytryptamine receptor 6 antagonist
2012,haloperidol,5-hydroxytryptamine receptor 7 antagonist
2014,ritonavir,Human immunodeficiency virus type 1 protease inhibitor
2016,ritonavir,Nuclear receptor subfamily 1 group I member 2 inhibitor
2020,trandolapril,Angiotensin-converting enzyme inhibitor
2021,carteolol,Beta-2 adrenergic receptor antagonist
2022,carteolol,Beta-2 adrenergic receptor partial agonist
2023,carteolol,Beta-1 adrenergic receptor antagonist
2024,carteolol,Beta-1 adrenergic receptor partial agonist
2026,foscarnet,DNA polymerase catalytic subunit inhibitor
2027,foscarnet,DNA polymerase catalytic subunit inhibitor
2031,erlotinib,Nuclear receptor subfamily 1 group I member 2 agonist
2032,rofecoxib,Prostaglandin G/H synthase 2 inhibitor
2040,ciprofloxacin,DNA topoisomerase 4 subunit A inhibitor
2041,ciprofloxacin,DNA gyrase subunit A inhibitor
2042,ciprofloxacin,DNA topoisomerase 2-alpha inhibitor
2043,ciprofloxacin,Potassium voltage-gated channel subfamily H member 2 inhibitor
2044,ciprofloxacin,DNA gyrase subunit A inhibitor
2045,ciprofloxacin,DNA topoisomerase 4 subunit A inhibitor
2047,ciprofloxacin,DNA gyrase subunit A inhibitor
2050,ciprofloxacin,DNA gyrase subunit A inhibitor
2051,nortriptyline,Sodium-dependent noradrenaline transporter inhibitor
2052,nortriptyline,Sodium-dependent noradrenaline transporter antagonist
2053,nortriptyline,Sodium-dependent noradrenaline transporter binder
2054,nortriptyline,Sodium-dependent serotonin transporter inhibitor
2055,nortriptyline,Sodium-dependent serotonin transporter antagonist
2056,nortriptyline,Sodium-dependent serotonin transporter binder
2057,nortriptyline,5-hydroxytryptamine receptor 2A inhibitor
2058,nortriptyline,5-hydroxytryptamine receptor 2A antagonist
2059,nortriptyline,5-hydroxytryptamine receptor 2A binder
2060,nortriptyline,5-hydroxytryptamine receptor 1A inhibitor
2061,nortriptyline,5-hydroxytryptamine receptor 1A antagonist
2062,nortriptyline,5-hydroxytryptamine receptor 1A binder
2063,nortriptyline,Histamine H1 receptor inhibitor
2064,nortriptyline,Histamine H1 receptor antagonist
2065,nortriptyline,Histamine H1 receptor binder
2066,nortriptyline,Alpha-1A adrenergic receptor inhibitor
2067,nortriptyline,Alpha-1A adrenergic receptor antagonist
2068,nortriptyline,Alpha-1A adrenergic receptor binder
2069,nortriptyline,Alpha-1D adrenergic receptor inhibitor
2070,nortriptyline,Alpha-1D adrenergic receptor antagonist
2071,nortriptyline,Alpha-1D adrenergic receptor binder
2072,nortriptyline,5-hydroxytryptamine receptor 2C inhibitor
2073,nortriptyline,5-hydroxytryptamine receptor 2C antagonist
2074,nortriptyline,5-hydroxytryptamine receptor 2C binder
2075,nortriptyline,Alpha-1B adrenergic receptor inhibitor
2076,nortriptyline,Alpha-1B adrenergic receptor antagonist
2077,nortriptyline,Alpha-1B adrenergic receptor binder
2078,nortriptyline,Alpha-2 adrenergic receptors inhibitor
2079,nortriptyline,Alpha-2 adrenergic receptors antagonist
2080,nortriptyline,Alpha-2 adrenergic receptors binder
2081,nortriptyline,Beta adrenergic receptor inhibitor
2084,nortriptyline,Dopamine D2 receptor inhibitor
2085,nortriptyline,Dopamine D2 receptor antagonist
2086,nortriptyline,Dopamine D2 receptor binder
2093,nortriptyline,Muscarinic acetylcholine receptor inhibitor
2094,nortriptyline,Muscarinic acetylcholine receptor antagonist
2095,nortriptyline,Muscarinic acetylcholine receptor binder
2098,benazepril,Angiotensin-converting enzyme inhibitor
2099,amoxapine,Sodium-dependent noradrenaline transporter inhibitor
2100,amoxapine,Sodium-dependent noradrenaline transporter antagonist
2101,amoxapine,Sodium-dependent noradrenaline transporter binder
2102,amoxapine,Sodium-dependent serotonin transporter inhibitor
2103,amoxapine,Sodium-dependent serotonin transporter antagonist
2104,amoxapine,Sodium-dependent serotonin transporter binder
2105,amoxapine,Dopamine D2 receptor inhibitor
2106,amoxapine,Dopamine D2 receptor antagonist
2107,amoxapine,Dopamine D2 receptor binder
2108,amoxapine,Dopamine D1 receptor inhibitor
2109,amoxapine,Dopamine D1 receptor antagonist
2111,amoxapine,Alpha-2A adrenergic receptor inhibitor
2112,amoxapine,Alpha-2A adrenergic receptor antagonist
2113,amoxapine,Alpha-2A adrenergic receptor binder
2114,amoxapine,Alpha-1A adrenergic receptor inhibitor
2115,amoxapine,Alpha-1A adrenergic receptor antagonist
2116,amoxapine,Alpha-1A adrenergic receptor binder
2117,amoxapine,Muscarinic acetylcholine receptor M1 inhibitor
2118,amoxapine,Muscarinic acetylcholine receptor M1 antagonist
2119,amoxapine,Muscarinic acetylcholine receptor M1 binder
2121,amoxapine,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
2123,amoxapine,5-hydroxytryptamine receptor 2A inhibitor
2124,amoxapine,5-hydroxytryptamine receptor 2A antagonist
2125,amoxapine,5-hydroxytryptamine receptor 2A binder
2126,amoxapine,5-hydroxytryptamine receptor 2C inhibitor
2127,amoxapine,5-hydroxytryptamine receptor 2C antagonist
2128,amoxapine,5-hydroxytryptamine receptor 2C binder
2129,amoxapine,5-hydroxytryptamine receptor 6 inhibitor
2130,amoxapine,5-hydroxytryptamine receptor 6 antagonist
2131,amoxapine,5-hydroxytryptamine receptor 6 binder
2132,amoxapine,5-hydroxytryptamine receptor 7 inhibitor
2133,amoxapine,5-hydroxytryptamine receptor 7 antagonist
2134,amoxapine,5-hydroxytryptamine receptor 7 binder
2135,amoxapine,Dopamine D3 receptor inhibitor
2136,amoxapine,Dopamine D3 receptor antagonist
2137,amoxapine,Dopamine D3 receptor binder
2139,amoxapine,Dopamine D4 receptor antagonist
2141,amoxapine,Histamine H1 receptor inhibitor
2142,amoxapine,Histamine H1 receptor antagonist
2143,amoxapine,Histamine H1 receptor binder
2144,amoxapine,Alpha-1 adrenergic receptors inhibitor
2145,amoxapine,Alpha-1 adrenergic receptors antagonist
2146,amoxapine,Alpha-1 adrenergic receptors binder
2147,amoxapine,Muscarinic acetylcholine receptor inhibitor
2148,amoxapine,Muscarinic acetylcholine receptor antagonist
2149,amoxapine,Muscarinic acetylcholine receptor binder
2150,amoxapine,5-hydroxytryptamine receptor 2B inhibitor
2151,amoxapine,5-hydroxytryptamine receptor 2B antagonist
2152,amoxapine,5-hydroxytryptamine receptor 2B binder
2153,amoxapine,5-hydroxytryptamine receptor 3A inhibitor
2154,amoxapine,5-hydroxytryptamine receptor 3A antagonist
2155,amoxapine,5-hydroxytryptamine receptor 3A binder
2156,amoxapine,5-hydroxytryptamine receptor 1A inhibitor
2157,amoxapine,5-hydroxytryptamine receptor 1A antagonist
2158,amoxapine,5-hydroxytryptamine receptor 1A binder
2160,amoxapine,5-hydroxytryptamine receptor 1B antagonist
2162,amoxapine,Alpha-2 adrenergic receptors inhibitor
2163,amoxapine,Alpha-2 adrenergic receptors antagonist
2164,amoxapine,Alpha-2 adrenergic receptors binder
2166,amoxapine,Histamine H4 receptor antagonist
2167,amoxapine,Histamine H4 receptor binder
2168,amoxapine,GABA(A) Receptor inhibitor
2169,amoxapine,GABA(A) Receptor antagonist
2171,amoxapine,Sodium-dependent dopamine transporter inhibitor
2172,amoxapine,Sodium-dependent dopamine transporter antagonist
2173,amoxapine,Sodium-dependent dopamine transporter binder
2174,pyridostigmine,Acetylcholinesterase inhibitor
2175,pyridostigmine,Cholinesterase inhibitor
2177,piroxicam,Prostaglandin G/H synthase 2 inhibitor
2178,piroxicam,Prostaglandin G/H synthase 1 inhibitor
2187,lamotrigine,Adenosine receptor A1 inhibitor
2189,lamotrigine,Adenosine receptor A1 antagonist
2195,lamotrigine,Alpha-1A adrenergic receptor inhibitor
2196,lamotrigine,Alpha-1A adrenergic receptor agonist
2197,lamotrigine,Alpha-1A adrenergic receptor antagonist
2199,lamotrigine,Alpha-2A adrenergic receptor inhibitor
2200,lamotrigine,Alpha-2A adrenergic receptor agonist
2201,lamotrigine,Alpha-2A adrenergic receptor antagonist
2203,lamotrigine,Beta-1 adrenergic receptor inhibitor
2204,lamotrigine,Beta-1 adrenergic receptor agonist
2205,lamotrigine,Beta-1 adrenergic receptor antagonist
2207,lamotrigine,D(1) dopamine receptor inhibitor
2208,lamotrigine,D(1) dopamine receptor agonist
2209,lamotrigine,D(1) dopamine receptor antagonist
2211,lamotrigine,Dopamine D2 receptor inhibitor
2212,lamotrigine,Dopamine D2 receptor agonist
2213,lamotrigine,Dopamine D2 receptor antagonist
2215,lamotrigine,GABA(A) Receptor inhibitor
2216,lamotrigine,GABA(A) Receptor agonist
2217,lamotrigine,GABA(A) Receptor antagonist
2223,lamotrigine,Histamine H1 receptor inhibitor
2224,lamotrigine,Histamine H1 receptor agonist
2225,lamotrigine,Histamine H1 receptor antagonist
2227,lamotrigine,Kappa-type opioid receptor inhibitor
2228,lamotrigine,Kappa-type opioid receptor agonist
2229,lamotrigine,Kappa-type opioid receptor antagonist
2235,lamotrigine,5-hydroxytryptamine receptor 2A inhibitor
2236,lamotrigine,5-hydroxytryptamine receptor 2A agonist
2237,lamotrigine,5-hydroxytryptamine receptor 2A antagonist
2239,lamotrigine,5-hydroxytryptamine receptor 3A inhibitor
2240,lamotrigine,5-hydroxytryptamine receptor 3A agonist
2241,lamotrigine,5-hydroxytryptamine receptor 3A antagonist
2258,methotrexate,Thymidylate synthase inhibitor
2262,carbamazepine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
2264,carbamazepine,Nuclear receptor subfamily 1 group I member 2 inhibitor
2266,cisatracurium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
2283,propranolol,Beta-1 adrenergic receptor antagonist
2285,propranolol,Beta-2 adrenergic receptor antagonist
2287,propranolol,Beta-3 adrenergic receptor antagonist
2289,propranolol,5-hydroxytryptamine receptor 1A antagonist
2290,propranolol,5-hydroxytryptamine receptor 1A other/unknown
2291,propranolol,5-hydroxytryptamine receptor 1B antagonist
2293,atropine,Muscarinic acetylcholine receptor M1 antagonist
2294,atropine,Muscarinic acetylcholine receptor M2 antagonist
2295,atropine,Muscarinic acetylcholine receptor M3 antagonist
2296,atropine,Muscarinic acetylcholine receptor M4 antagonist
2297,atropine,Muscarinic acetylcholine receptor M5 antagonist
2299,atropine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
2301,fenoprofen,Prostaglandin G/H synthase 2 inhibitor
2303,fenoprofen,Prostaglandin G/H synthase 1 inhibitor
2305,fenoprofen,Peroxisome proliferator-activated receptor alpha inhibitor
2307,fenoprofen,Peroxisome proliferator-activated receptor gamma inhibitor
2309,clonidine,Alpha-2A adrenergic receptor agonist
2310,clonidine,Alpha-2B adrenergic receptor agonist
2311,clonidine,Alpha-2C adrenergic receptor agonist
2312,clonidine,Alpha-1A adrenergic receptor agonist
2313,clonidine,Alpha-1B adrenergic receptor agonist
2314,clonidine,Alpha-1D adrenergic receptor agonist
2315,valdecoxib,Prostaglandin G/H synthase 2 inhibitor
2316,valdecoxib,Carbonic anhydrase 2 inhibitor
2317,valdecoxib,Carbonic anhydrase 3 inhibitor
2320,nizatidine,Histamine H2 receptor antagonist
2321,diclofenac,Prostaglandin G/H synthase 2 inhibitor
2322,diclofenac,Prostaglandin G/H synthase 1 inhibitor
2323,lisuride,Dopamine D2 receptor agonist
2324,lisuride,Dopamine D2 receptor antagonist
2325,lisuride,Dopamine D2 receptor other/unknown
2326,lisuride,Dopamine D3 receptor agonist
2327,lisuride,Dopamine D3 receptor antagonist
2329,lisuride,Dopamine D4 receptor agonist
2330,lisuride,Dopamine D4 receptor antagonist
2332,lisuride,Dopamine D1 receptor agonist
2333,lisuride,Dopamine D1 receptor antagonist
2335,lisuride,Dopamine D5 receptor agonist
2336,lisuride,Dopamine D5 receptor antagonist
2338,lisuride,5-hydroxytryptamine receptor 1A agonist
2339,lisuride,5-hydroxytryptamine receptor 1A antagonist
2340,lisuride,5-hydroxytryptamine receptor 1A other/unknown
2341,lisuride,5-hydroxytryptamine receptor 1D agonist
2342,lisuride,5-hydroxytryptamine receptor 1D antagonist
2344,lisuride,5-hydroxytryptamine receptor 2B agonist
2345,lisuride,5-hydroxytryptamine receptor 2B antagonist
2347,lisuride,5-hydroxytryptamine receptor 2A agonist
2348,lisuride,5-hydroxytryptamine receptor 2A antagonist
2349,lisuride,5-hydroxytryptamine receptor 2A other/unknown
2350,lisuride,5-hydroxytryptamine receptor 2C agonist
2351,lisuride,5-hydroxytryptamine receptor 2C antagonist
2353,lisuride,5-hydroxytryptamine receptor 1B agonist
2354,lisuride,5-hydroxytryptamine receptor 1B antagonist
2356,lisuride,Alpha-2A adrenergic receptor agonist
2357,lisuride,Alpha-2A adrenergic receptor antagonist
2359,lisuride,Alpha-2B adrenergic receptor agonist
2360,lisuride,Alpha-2B adrenergic receptor antagonist
2362,lisuride,Alpha-2C adrenergic receptor agonist
2363,lisuride,Alpha-2C adrenergic receptor antagonist
2365,lisuride,5-hydroxytryptamine receptor 7 agonist
2366,lisuride,5-hydroxytryptamine receptor 7 antagonist
2368,doxazosin,Alpha-1A adrenergic receptor antagonist
2369,doxazosin,Alpha-1A adrenergic receptor inhibitor
2370,doxazosin,Alpha-1D adrenergic receptor antagonist
2371,doxazosin,Alpha-1D adrenergic receptor inhibitor
2374,doxazosin,Alpha-1B adrenergic receptor antagonist
2375,doxazosin,Alpha-1B adrenergic receptor inhibitor
2388,labetalol,Beta-1 adrenergic receptor antagonist
2389,labetalol,Beta-2 adrenergic receptor antagonist
2390,labetalol,Alpha-1 adrenergic receptors antagonist
2392,sulindac,Prostaglandin G/H synthase 2 inhibitor
2394,sulindac,Prostaglandin G/H synthase 1 inhibitor
2413,butorphanol,Kappa-type opioid receptor agonist
2414,butorphanol,Kappa-type opioid receptor antagonist
2415,butorphanol,Delta-type opioid receptor agonist
2416,butorphanol,Delta-type opioid receptor antagonist
2417,butorphanol,Mu-type opioid receptor agonist
2418,butorphanol,Mu-type opioid receptor antagonist
2419,bisoprolol,Beta-1 adrenergic receptor antagonist
2420,bisoprolol,Beta-2 adrenergic receptor antagonist
2425,imatinib,Mast/stem cell growth factor receptor Kit inhibitor
2437,imatinib,Tyrosine-protein kinase ABL1 inhibitor
2439,imatinib,Platelet-derived growth factor receptor beta inhibitor
2441,triamcinolone,Glucocorticoid receptor agonist
2442,nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
2445,nicardipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
2448,nicardipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
2451,nicardipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
2460,nicardipine,Alpha-1A adrenergic receptor inhibitor
2461,nicardipine,Alpha-1A adrenergic receptor antagonist
2463,nicardipine,Alpha-1B adrenergic receptor inhibitor
2464,nicardipine,Alpha-1B adrenergic receptor antagonist
2466,nicardipine,Alpha-1D adrenergic receptor inhibitor
2467,nicardipine,Alpha-1D adrenergic receptor antagonist
2469,nicardipine,Muscarinic acetylcholine receptor M1 inhibitor
2470,nicardipine,Muscarinic acetylcholine receptor M1 antagonist
2472,nicardipine,Muscarinic acetylcholine receptor M2 inhibitor
2473,nicardipine,Muscarinic acetylcholine receptor M2 antagonist
2475,nicardipine,Muscarinic acetylcholine receptor M3 inhibitor
2476,nicardipine,Muscarinic acetylcholine receptor M3 antagonist
2478,nicardipine,Muscarinic acetylcholine receptor M4 inhibitor
2479,nicardipine,Muscarinic acetylcholine receptor M4 antagonist
2481,nicardipine,Muscarinic acetylcholine receptor M5 inhibitor
2482,nicardipine,Muscarinic acetylcholine receptor M5 antagonist
2484,nicardipine,Calmodulin inhibitor
2485,nicardipine,Calmodulin antagonist
2487,fluphenazine,Dopamine D2 receptor antagonist
2488,fluphenazine,Dopamine D2 receptor inhibitor
2489,fluphenazine,Dopamine D1 receptor antagonist
2490,fluphenazine,Dopamine D1 receptor inhibitor
2491,fluphenazine,Calmodulin antagonist
2492,fluphenazine,Calmodulin inhibitor
2493,fluphenazine,Androgen receptor antagonist
2494,fluphenazine,Androgen receptor inhibitor
2495,fluphenazine,5-hydroxytryptamine receptor 2A antagonist
2496,fluphenazine,5-hydroxytryptamine receptor 2A inhibitor
2497,fluphenazine,5-hydroxytryptamine receptor 2C antagonist
2498,fluphenazine,5-hydroxytryptamine receptor 2C inhibitor
2499,testosterone,Androgen receptor agonist
2500,testosterone,Androgen receptor inhibitor
2502,testosterone,Estrogen receptor alpha agonist
2503,testosterone,Estrogen receptor alpha inhibitor
2508,efavirenz,Reverse transcriptase/RNaseH inhibitor
2521,clofarabine,DNA inhibitor
2523,dexmedetomidine,Alpha-2A adrenergic receptor agonist
2524,prednisone,Glucocorticoid receptor agonist
2529,pemetrexed,Thymidylate synthase inhibitor
2542,dyphylline,Adenosine receptor A1 inhibitor
2543,dyphylline,Adenosine receptor A1 antagonist
2546,pentazocine,Mu-type opioid receptor antagonist
2547,pentazocine,Mu-type opioid receptor agonist
2548,pentazocine,Kappa-type opioid receptor antagonist
2549,pentazocine,Kappa-type opioid receptor agonist
2552,estrone,Estrogen receptor alpha agonist
2553,estrone,Estrogen receptor beta agonist
2554,estrone,Androgen receptor agonist
2557,trazodone,5-hydroxytryptamine receptor 2A antagonist
2558,trazodone,5-hydroxytryptamine receptor 2A agonist
2559,trazodone,5-hydroxytryptamine receptor 2A inhibitor
2561,trazodone,5-hydroxytryptamine receptor 2C antagonist
2562,trazodone,5-hydroxytryptamine receptor 2C agonist
2563,trazodone,5-hydroxytryptamine receptor 2C inhibitor
2565,trazodone,Sodium-dependent serotonin transporter antagonist
2566,trazodone,Sodium-dependent serotonin transporter agonist
2567,trazodone,Sodium-dependent serotonin transporter inhibitor
2569,trazodone,5-hydroxytryptamine receptor 1A antagonist
2570,trazodone,5-hydroxytryptamine receptor 1A agonist
2571,trazodone,5-hydroxytryptamine receptor 1A inhibitor
2572,trazodone,5-hydroxytryptamine receptor 1A partial agonist
2573,trazodone,Histamine H1 receptor antagonist
2574,trazodone,Histamine H1 receptor agonist
2575,trazodone,Histamine H1 receptor inhibitor
2577,trazodone,Alpha-1A adrenergic receptor antagonist
2578,trazodone,Alpha-1A adrenergic receptor agonist
2579,trazodone,Alpha-1A adrenergic receptor inhibitor
2581,trazodone,Alpha-2A adrenergic receptor antagonist
2582,trazodone,Alpha-2A adrenergic receptor agonist
2583,trazodone,Alpha-2A adrenergic receptor inhibitor
2595,verapamil,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
2607,verapamil,Potassium voltage-gated channel subfamily H member 2 inhibitor
2608,verapamil,Potassium voltage-gated channel subfamily H member 2 antagonist
2609,verapamil,Sodium-dependent serotonin transporter inhibitor
2610,verapamil,Sodium-dependent serotonin transporter antagonist
2611,verapamil,Alpha-1A adrenergic receptor inhibitor
2612,verapamil,Alpha-1A adrenergic receptor antagonist
2613,verapamil,Alpha-1B adrenergic receptor inhibitor
2614,verapamil,Alpha-1B adrenergic receptor antagonist
2615,verapamil,Alpha-1D adrenergic receptor inhibitor
2616,verapamil,Alpha-1D adrenergic receptor antagonist
2617,nilutamide,Androgen receptor antagonist
2620,epinephrine,Alpha-1A adrenergic receptor agonist
2621,epinephrine,Alpha-1A adrenergic receptor antagonist
2622,epinephrine,Alpha-1B adrenergic receptor agonist
2623,epinephrine,Alpha-1B adrenergic receptor antagonist
2624,epinephrine,Beta-1 adrenergic receptor agonist
2625,epinephrine,Beta-1 adrenergic receptor antagonist
2626,epinephrine,Beta-2 adrenergic receptor agonist
2627,epinephrine,Beta-2 adrenergic receptor antagonist
2628,epinephrine,Alpha-2A adrenergic receptor agonist
2629,epinephrine,Alpha-2A adrenergic receptor antagonist
2630,epinephrine,Alpha-2B adrenergic receptor agonist
2631,epinephrine,Alpha-2B adrenergic receptor antagonist
2632,epinephrine,Alpha-1D adrenergic receptor agonist
2633,epinephrine,Alpha-1D adrenergic receptor antagonist
2636,sumatriptan,5-hydroxytryptamine receptor 1D agonist
2637,sumatriptan,5-hydroxytryptamine receptor 1B agonist
2638,sumatriptan,5-hydroxytryptamine receptor 1F agonist
2639,sumatriptan,5-hydroxytryptamine receptor 1A agonist
2641,galantamine,Acetylcholinesterase inhibitor
2644,galantamine,Cholinesterase inhibitor
2645,tamoxifen,Estrogen receptor alpha antagonist
2646,tamoxifen,Estrogen receptor alpha agonist
2647,tamoxifen,Estrogen receptor alpha inhibitor
2650,tamoxifen,Estrogen receptor beta agonist
2661,tamoxifen,Androgen receptor antagonist
2662,tamoxifen,Androgen receptor agonist
2663,tamoxifen,Androgen receptor inhibitor
2665,tamoxifen,Potassium voltage-gated channel subfamily H member 2 antagonist
2667,tamoxifen,Potassium voltage-gated channel subfamily H member 2 inhibitor
2670,tamoxifen,Nuclear receptor subfamily 1 group I member 2 agonist
2671,tamoxifen,Nuclear receptor subfamily 1 group I member 2 inhibitor
2685,losartan,Type-1 angiotensin II receptor antagonist
2686,thioridazine,Dopamine D2 receptor antagonist
2687,thioridazine,Dopamine D2 receptor inhibitor
2688,thioridazine,Dopamine D1 receptor antagonist
2689,thioridazine,Dopamine D1 receptor inhibitor
2690,thioridazine,Alpha-1A adrenergic receptor antagonist
2691,thioridazine,Alpha-1A adrenergic receptor inhibitor
2692,thioridazine,Alpha-1B adrenergic receptor antagonist
2693,thioridazine,Alpha-1B adrenergic receptor inhibitor
2694,thioridazine,5-hydroxytryptamine receptor 2A antagonist
2695,thioridazine,5-hydroxytryptamine receptor 2A inhibitor
2696,thioridazine,Potassium voltage-gated channel subfamily H member 2 antagonist
2697,thioridazine,Potassium voltage-gated channel subfamily H member 2 inhibitor
2698,midazolam,GABA(A) Receptor ligand
2699,midazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
2700,trovafloxacin,DNA gyrase subunit A inhibitor
2701,trovafloxacin,DNA topoisomerase 4 subunit A inhibitor
2702,trovafloxacin,DNA topoisomerase 2-alpha inhibitor
2704,fludrocortisone,Glucocorticoid receptor agonist
2705,phentolamine,Alpha-2A adrenergic receptor antagonist
2706,phentolamine,Alpha-1A adrenergic receptor antagonist
2707,phentolamine,Alpha-1B adrenergic receptor antagonist
2708,phentolamine,Alpha-1D adrenergic receptor antagonist
2709,ergotamine,5-hydroxytryptamine receptor 1D agonist
2711,ergotamine,5-hydroxytryptamine receptor 1B agonist
2713,ergotamine,5-hydroxytryptamine receptor 2A agonist
2715,ergotamine,Dopamine D2 receptor agonist
2717,ergotamine,Alpha-1A adrenergic receptor agonist
2719,ergotamine,Alpha-1B adrenergic receptor agonist
2721,ergotamine,Alpha-1D adrenergic receptor agonist
2723,ergotamine,Alpha-2A adrenergic receptor agonist
2725,ergotamine,D(1) dopamine receptor agonist
2727,ergotamine,5-hydroxytryptamine receptor 1A agonist
2728,ergotamine,5-hydroxytryptamine receptor 1A partial agonist
2729,ergotamine,5-hydroxytryptamine receptor 1F agonist
2731,ergotamine,5-hydroxytryptamine receptor 2C agonist
2733,ergotamine,5-hydroxytryptamine receptor 2B agonist
2735,ergotamine,Alpha-2C adrenergic receptor agonist
2737,tizanidine,Alpha-2 adrenergic receptors agonist
2739,tizanidine,Alpha-1 adrenergic receptors agonist
2747,amprenavir,Human immunodeficiency virus type 1 protease inhibitor
2748,naltrexone,Delta-type opioid receptor antagonist
2749,naltrexone,Mu-type opioid receptor antagonist
2750,naltrexone,Kappa-type opioid receptor antagonist
2752,delavirdine,Reverse transcriptase/RNaseH inhibitor
2753,tamsulosin,Alpha-1A adrenergic receptor antagonist
2754,tamsulosin,Alpha-1D adrenergic receptor antagonist
2755,tamsulosin,Alpha-1B adrenergic receptor antagonist
2756,sufentanil,Mu-type opioid receptor agonist
2757,sufentanil,Delta-type opioid receptor agonist
2758,sufentanil,Kappa-type opioid receptor agonist
2759,lamivudine,Reverse transcriptase/RNaseH inhibitor
2761,lamivudine,DNA inhibitor
2771,flurbiprofen,Prostaglandin G/H synthase 1 inhibitor
2772,flurbiprofen,Prostaglandin G/H synthase 2 inhibitor
2773,apomorphine,Dopamine D4 receptor agonist
2774,apomorphine,Dopamine D2 receptor agonist
2775,apomorphine,Dopamine D3 receptor agonist
2776,apomorphine,Dopamine D5 receptor agonist
2777,apomorphine,Dopamine D1 receptor agonist
2778,apomorphine,Alpha-2C adrenergic receptor agonist
2779,apomorphine,Alpha-2B adrenergic receptor agonist
2780,apomorphine,5-hydroxytryptamine receptor 1A agonist
2781,apomorphine,5-hydroxytryptamine receptor 2A agonist
2782,apomorphine,5-hydroxytryptamine receptor 2B agonist
2783,apomorphine,5-hydroxytryptamine receptor 2C agonist
2784,apomorphine,Alpha-2A adrenergic receptor agonist
2785,apomorphine,5-hydroxytryptamine receptor 1D agonist
2786,apomorphine,5-hydroxytryptamine receptor 1B agonist
2787,paroxetine,Sodium-dependent serotonin transporter inhibitor
2788,paroxetine,Sodium-dependent serotonin transporter agonist
2789,paroxetine,Sodium-dependent serotonin transporter binder
2791,paroxetine,Sodium-dependent noradrenaline transporter inhibitor
2792,paroxetine,Sodium-dependent noradrenaline transporter agonist
2793,paroxetine,Sodium-dependent noradrenaline transporter binder
2795,paroxetine,5-hydroxytryptamine receptor 2A inhibitor
2796,paroxetine,5-hydroxytryptamine receptor 2A agonist
2797,paroxetine,5-hydroxytryptamine receptor 2A binder
2798,paroxetine,5-hydroxytryptamine receptor 2A other/unknown
2799,paroxetine,Alpha-1 adrenergic receptors inhibitor
2800,paroxetine,Alpha-1 adrenergic receptors agonist
2801,paroxetine,Alpha-1 adrenergic receptors binder
2803,paroxetine,Alpha-2 adrenergic receptors inhibitor
2804,paroxetine,Alpha-2 adrenergic receptors agonist
2805,paroxetine,Alpha-2 adrenergic receptors binder
2807,paroxetine,Beta adrenergic receptor inhibitor
2811,paroxetine,Dopamine D2 receptor inhibitor
2812,paroxetine,Dopamine D2 receptor agonist
2813,paroxetine,Dopamine D2 receptor binder
2814,paroxetine,Dopamine D2 receptor other/unknown
2815,paroxetine,Histamine H1 receptor inhibitor
2816,paroxetine,Histamine H1 receptor agonist
2817,paroxetine,Histamine H1 receptor binder
2823,paroxetine,Muscarinic acetylcholine receptor inhibitor
2825,paroxetine,Muscarinic acetylcholine receptor binder
2827,paroxetine,5-hydroxytryptamine receptor 2B inhibitor
2828,paroxetine,5-hydroxytryptamine receptor 2B agonist
2829,paroxetine,5-hydroxytryptamine receptor 2B binder
2831,paroxetine,D(1) dopamine receptor inhibitor
2832,paroxetine,D(1) dopamine receptor agonist
2833,paroxetine,D(1) dopamine receptor binder
2836,norethisterone,Androgen receptor agonist
2837,norethisterone,Glucocorticoid receptor agonist
2838,procaine,Sodium channel protein type 10 subunit alpha inhibitor
2842,procaine,5-hydroxytryptamine receptor 3A inhibitor
2843,procaine,5-hydroxytryptamine receptor 3A antagonist
2844,procaine,Sodium-dependent dopamine transporter inhibitor
2845,procaine,Sodium-dependent dopamine transporter antagonist
2847,procaine,Neuronal acetylcholine receptor subunit alpha-2 antagonist
2860,lisinopril,Angiotensin-converting enzyme inhibitor
2864,trimipramine,Sodium-dependent serotonin transporter inhibitor
2865,trimipramine,Sodium-dependent serotonin transporter agonist
2866,trimipramine,Sodium-dependent serotonin transporter antagonist
2868,trimipramine,Sodium-dependent serotonin transporter binder
2869,trimipramine,Sodium-dependent noradrenaline transporter inhibitor
2870,trimipramine,Sodium-dependent noradrenaline transporter agonist
2871,trimipramine,Sodium-dependent noradrenaline transporter antagonist
2873,trimipramine,Sodium-dependent noradrenaline transporter binder
2874,trimipramine,Sodium-dependent dopamine transporter inhibitor
2875,trimipramine,Sodium-dependent dopamine transporter agonist
2876,trimipramine,Sodium-dependent dopamine transporter antagonist
2878,trimipramine,Sodium-dependent dopamine transporter binder
2879,trimipramine,5-hydroxytryptamine receptor 2A inhibitor
2880,trimipramine,5-hydroxytryptamine receptor 2A agonist
2881,trimipramine,5-hydroxytryptamine receptor 2A antagonist
2882,trimipramine,5-hydroxytryptamine receptor 2A other/unknown
2883,trimipramine,5-hydroxytryptamine receptor 2A binder
2884,trimipramine,5-hydroxytryptamine receptor 1A inhibitor
2885,trimipramine,5-hydroxytryptamine receptor 1A agonist
2886,trimipramine,5-hydroxytryptamine receptor 1A antagonist
2887,trimipramine,5-hydroxytryptamine receptor 1A other/unknown
2888,trimipramine,5-hydroxytryptamine receptor 1A binder
2889,trimipramine,Alpha-1A adrenergic receptor inhibitor
2890,trimipramine,Alpha-1A adrenergic receptor agonist
2891,trimipramine,Alpha-1A adrenergic receptor antagonist
2893,trimipramine,Alpha-1A adrenergic receptor binder
2894,trimipramine,Alpha-1B adrenergic receptor inhibitor
2895,trimipramine,Alpha-1B adrenergic receptor agonist
2896,trimipramine,Alpha-1B adrenergic receptor antagonist
2898,trimipramine,Alpha-1B adrenergic receptor binder
2899,trimipramine,Dopamine D2 receptor inhibitor
2900,trimipramine,Dopamine D2 receptor agonist
2901,trimipramine,Dopamine D2 receptor antagonist
2902,trimipramine,Dopamine D2 receptor other/unknown
2903,trimipramine,Dopamine D2 receptor binder
2904,trimipramine,Alpha-2B adrenergic receptor inhibitor
2905,trimipramine,Alpha-2B adrenergic receptor agonist
2906,trimipramine,Alpha-2B adrenergic receptor antagonist
2908,trimipramine,Alpha-2B adrenergic receptor binder
2909,trimipramine,Histamine H1 receptor inhibitor
2910,trimipramine,Histamine H1 receptor agonist
2911,trimipramine,Histamine H1 receptor antagonist
2913,trimipramine,Histamine H1 receptor binder
2914,trimipramine,5-hydroxytryptamine receptor 2C inhibitor
2915,trimipramine,5-hydroxytryptamine receptor 2C agonist
2916,trimipramine,5-hydroxytryptamine receptor 2C antagonist
2918,trimipramine,5-hydroxytryptamine receptor 2C binder
2919,trimipramine,5-hydroxytryptamine receptor 3A inhibitor
2920,trimipramine,5-hydroxytryptamine receptor 3A agonist
2921,trimipramine,5-hydroxytryptamine receptor 3A antagonist
2923,trimipramine,5-hydroxytryptamine receptor 3A binder
2925,trimipramine,5-hydroxytryptamine receptor 1D agonist
2926,trimipramine,5-hydroxytryptamine receptor 1D antagonist
2929,trimipramine,Alpha-2A adrenergic receptor inhibitor
2930,trimipramine,Alpha-2A adrenergic receptor agonist
2931,trimipramine,Alpha-2A adrenergic receptor antagonist
2933,trimipramine,Alpha-2A adrenergic receptor binder
2934,trimipramine,D(1) dopamine receptor inhibitor
2935,trimipramine,D(1) dopamine receptor agonist
2936,trimipramine,D(1) dopamine receptor antagonist
2938,trimipramine,D(1) dopamine receptor binder
2939,trimipramine,Beta adrenergic receptor inhibitor
2944,trimipramine,Muscarinic acetylcholine receptor inhibitor
2946,trimipramine,Muscarinic acetylcholine receptor antagonist
2948,trimipramine,Muscarinic acetylcholine receptor binder
2955,rocuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
2956,rocuronium,Muscarinic acetylcholine receptor M2 antagonist
2957,rocuronium,5-hydroxytryptamine receptor 3A antagonist
2960,risperidone,5-hydroxytryptamine receptor 2A antagonist
2961,risperidone,Dopamine D2 receptor antagonist
2962,risperidone,Alpha-1B adrenergic receptor antagonist
2963,risperidone,Alpha-2B adrenergic receptor antagonist
2964,risperidone,Alpha-1A adrenergic receptor antagonist
2965,risperidone,Alpha-2C adrenergic receptor antagonist
2966,risperidone,Histamine H1 receptor antagonist
2967,risperidone,5-hydroxytryptamine receptor 2C antagonist
2968,risperidone,5-hydroxytryptamine receptor 1D antagonist
2969,risperidone,5-hydroxytryptamine receptor 1A antagonist
2970,risperidone,5-hydroxytryptamine receptor 7 antagonist
2972,risperidone,Dopamine D1 receptor antagonist
2975,riluzole,Sodium channel protein type 5 subunit alpha inhibitor
2979,modafinil,Sodium-dependent dopamine transporter inhibitor
2981,modafinil,Alpha-1B adrenergic receptor inhibitor
2983,scopolamine,Muscarinic acetylcholine receptor M1 antagonist
2984,scopolamine,Muscarinic acetylcholine receptor M1 inhibitor
2986,scopolamine,Muscarinic acetylcholine receptor M2 antagonist
2987,scopolamine,Muscarinic acetylcholine receptor M2 inhibitor
2989,scopolamine,Muscarinic acetylcholine receptor M3 antagonist
2990,scopolamine,Muscarinic acetylcholine receptor M3 inhibitor
2992,scopolamine,Muscarinic acetylcholine receptor M4 antagonist
2993,scopolamine,Muscarinic acetylcholine receptor M4 inhibitor
2995,scopolamine,Muscarinic acetylcholine receptor M5 antagonist
2996,scopolamine,Muscarinic acetylcholine receptor M5 inhibitor
2998,scopolamine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
2999,scopolamine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
3007,carbinoxamine,Histamine H1 receptor antagonist
3008,etodolac,Prostaglandin G/H synthase 2 inhibitor
3009,etodolac,Prostaglandin G/H synthase 1 inhibitor
3011,prilocaine,Sodium channel protein type 5 subunit alpha inhibitor
3012,tranylcypromine,Amine oxidase [flavin-containing] B inhibitor
3014,isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
3016,isoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
3045,isoflurane,Calmodulin inhibitor
3046,isoflurane,Calmodulin antagonist
3049,isoflurane,GABA(A) Receptor agonist
3050,isoflurane,GABA(A) Receptor inhibitor
3051,isoflurane,GABA(A) Receptor antagonist
3054,isoflurane,Neuronal acetylcholine receptor subunit alpha-4 agonist
3055,isoflurane,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
3056,isoflurane,Neuronal acetylcholine receptor subunit alpha-4 antagonist
3064,dolasetron,5-hydroxytryptamine receptor 3A antagonist
3078,etoposide,DNA topoisomerase 2-alpha inhibitor
3086,phenelzine,Amine oxidase [flavin-containing] B inhibitor
3097,propantheline,Muscarinic acetylcholine receptor M1 antagonist
3098,estradiol,Estrogen receptor alpha agonist
3100,estradiol,Estrogen receptor alpha inhibitor
3101,estradiol,Estrogen receptor beta agonist
3104,estradiol,Nuclear receptor subfamily 1 group I member 2 agonist
3106,estradiol,Nuclear receptor subfamily 1 group I member 2 inhibitor
3107,estradiol,Neuronal acetylcholine receptor subunit alpha-4 agonist
3109,estradiol,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
3122,acyclovir,DNA polymerase catalytic subunit inhibitor
3124,acyclovir,DNA polymerase catalytic subunit inhibitor
3125,naproxen,Prostaglandin G/H synthase 1 inhibitor
3127,naproxen,Prostaglandin G/H synthase 2 inhibitor
3128,perindopril,Angiotensin-converting enzyme inhibitor
3133,sulfasalazine,Prostaglandin G/H synthase 2 inhibitor
3136,sulfasalazine,Prostaglandin G/H synthase 1 inhibitor
3139,sulfasalazine,Peroxisome proliferator-activated receptor gamma inhibitor
3140,sulfasalazine,Peroxisome proliferator-activated receptor gamma agonist
3160,fenoldopam,Dopamine D5 receptor agonist
3161,fenoldopam,Dopamine D5 receptor antagonist
3163,fenoldopam,Dopamine D1 receptor agonist
3164,fenoldopam,Dopamine D1 receptor antagonist
3165,fenoldopam,Dopamine D1 receptor inhibitor
3166,fenoldopam,Alpha-2B adrenergic receptor agonist
3167,fenoldopam,Alpha-2B adrenergic receptor antagonist
3168,fenoldopam,Alpha-2B adrenergic receptor inhibitor
3169,fenoldopam,Alpha-2C adrenergic receptor agonist
3170,fenoldopam,Alpha-2C adrenergic receptor antagonist
3171,fenoldopam,Alpha-2C adrenergic receptor inhibitor
3172,fenoldopam,Alpha-2A adrenergic receptor agonist
3173,fenoldopam,Alpha-2A adrenergic receptor antagonist
3174,fenoldopam,Alpha-2A adrenergic receptor inhibitor
3175,fenoldopam,Alpha-1B adrenergic receptor agonist
3176,fenoldopam,Alpha-1B adrenergic receptor antagonist
3177,fenoldopam,Alpha-1B adrenergic receptor inhibitor
3178,fenoldopam,Alpha-1D adrenergic receptor agonist
3179,fenoldopam,Alpha-1D adrenergic receptor antagonist
3180,fenoldopam,Alpha-1D adrenergic receptor inhibitor
3181,fenoldopam,Alpha-1A adrenergic receptor agonist
3182,fenoldopam,Alpha-1A adrenergic receptor antagonist
3183,fenoldopam,Alpha-1A adrenergic receptor inhibitor
3184,alfentanil,Mu-type opioid receptor agonist
3185,dicyclomine,Muscarinic acetylcholine receptor M1 antagonist
3186,dicyclomine,Muscarinic acetylcholine receptor M3 antagonist
3187,dicyclomine,Muscarinic acetylcholine receptor M2 antagonist
3193,pentoxifylline,Adenosine receptor A1 inhibitor
3197,tropicamide,Muscarinic acetylcholine receptor M4 antagonist
3198,tropicamide,Muscarinic acetylcholine receptor M3 antagonist
3199,tropicamide,Muscarinic acetylcholine receptor M1 antagonist
3200,tropicamide,Muscarinic acetylcholine receptor M2 antagonist
3211,fentanyl,Mu-type opioid receptor agonist
3212,fentanyl,Delta-type opioid receptor agonist
3213,fentanyl,Kappa-type opioid receptor agonist
3215,meloxicam,Prostaglandin G/H synthase 2 inhibitor
3216,meloxicam,Prostaglandin G/H synthase 1 inhibitor
3226,propofol,GABA(A) Receptor inhibitor
3227,tadalafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
3230,diazepam,GABA(A) Receptor ligand
3231,diazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
3232,trifluoperazine,Dopamine D2 receptor antagonist
3233,trifluoperazine,Dopamine D2 receptor inhibitor
3236,trifluoperazine,Alpha-1A adrenergic receptor antagonist
3237,trifluoperazine,Alpha-1A adrenergic receptor inhibitor
3238,trifluoperazine,Calmodulin antagonist
3239,trifluoperazine,Calmodulin inhibitor
3246,dobutamine,Beta-1 adrenergic receptor agonist
3247,dobutamine,Beta-2 adrenergic receptor agonist
3248,dobutamine,Alpha-1 adrenergic receptors agonist
3249,dobutamine,Estrogen receptor alpha agonist
3250,donepezil,Acetylcholinesterase inhibitor
3252,donepezil,5-hydroxytryptamine receptor 2A inhibitor
3254,donepezil,Cholinesterase inhibitor
3266,nalbuphine,Kappa-type opioid receptor agonist
3267,nalbuphine,Kappa-type opioid receptor antagonist
3268,nalbuphine,Mu-type opioid receptor agonist
3269,nalbuphine,Mu-type opioid receptor antagonist
3270,nalbuphine,Delta-type opioid receptor agonist
3271,nalbuphine,Delta-type opioid receptor antagonist
3272,perphenazine,Dopamine D2 receptor antagonist
3273,perphenazine,Dopamine D2 receptor inhibitor
3274,perphenazine,Dopamine D1 receptor antagonist
3275,perphenazine,Dopamine D1 receptor inhibitor
3276,perphenazine,Calmodulin antagonist
3277,perphenazine,Calmodulin inhibitor
3278,prednisolone,Glucocorticoid receptor agonist
3279,vardenafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
3282,ranitidine,Histamine H2 receptor antagonist
3285,ranitidine,Acetylcholinesterase inhibitor
3289,benzphetamine,Synaptic vesicular amine transporter inhibitor
3291,benzphetamine,Alpha-2A adrenergic receptor agonist
3292,benzphetamine,Alpha-2A adrenergic receptor inhibitor
3294,benzphetamine,Alpha-1A adrenergic receptor agonist
3295,benzphetamine,Alpha-1A adrenergic receptor inhibitor
3297,benzphetamine,Sodium-dependent dopamine transporter agonist
3298,benzphetamine,Sodium-dependent dopamine transporter inhibitor
3299,dorzolamide,Carbonic anhydrase 2 inhibitor
3301,dorzolamide,Carbonic anhydrase 1 inhibitor
3302,dorzolamide,Carbonic anhydrase 3 inhibitor
3303,terbutaline,Beta-2 adrenergic receptor agonist
3304,terbutaline,Beta-2 adrenergic receptor antagonist
3305,terbutaline,Beta-3 adrenergic receptor agonist
3306,terbutaline,Beta-3 adrenergic receptor antagonist
3307,terbutaline,Beta-1 adrenergic receptor agonist
3308,terbutaline,Beta-1 adrenergic receptor antagonist
3311,eprosartan,Type-1 angiotensin II receptor antagonist
3312,quinapril,Angiotensin-converting enzyme inhibitor
3313,granisetron,5-hydroxytryptamine receptor 3A antagonist
3314,triazolam,GABA(A) Receptor ligand
3315,triazolam,GABA(A) Receptor Benzodiazepine Binding Site ligand
3316,remifentanil,Mu-type opioid receptor agonist
3317,remifentanil,Delta-type opioid receptor agonist
3318,remifentanil,Kappa-type opioid receptor agonist
3319,ondansetron,5-hydroxytryptamine receptor 3A antagonist
3320,ondansetron,5-hydroxytryptamine receptor 3A agonist
3325,ondansetron,Mu-type opioid receptor antagonist
3326,ondansetron,Mu-type opioid receptor agonist
3328,ondansetron,5-hydroxytryptamine receptor 1A antagonist
3329,ondansetron,5-hydroxytryptamine receptor 1A agonist
3330,ondansetron,5-hydroxytryptamine receptor 1A other/unknown
3331,ondansetron,5-hydroxytryptamine receptor 1B antagonist
3332,ondansetron,5-hydroxytryptamine receptor 1B agonist
3335,quinidine,Sodium channel protein type 5 subunit alpha inhibitor
3341,quinidine,Potassium voltage-gated channel subfamily H member 2 inhibitor
3342,quinidine,Potassium voltage-gated channel subfamily H member 2 antagonist
3343,quinidine,Alpha-1A adrenergic receptor inhibitor
3344,quinidine,Alpha-1A adrenergic receptor antagonist
3345,quinidine,Alpha-1B adrenergic receptor inhibitor
3346,quinidine,Alpha-1B adrenergic receptor antagonist
3347,quinidine,Alpha-1D adrenergic receptor inhibitor
3348,quinidine,Alpha-1D adrenergic receptor antagonist
3353,zonisamide,Sodium channel protein type 5 subunit alpha inhibitor
3363,zonisamide,Carbonic anhydrase 1 inhibitor
3364,zonisamide,Carbonic anhydrase 2 inhibitor
3365,zonisamide,Carbonic anhydrase 3 inhibitor
3378,zonisamide,Amine oxidase [flavin-containing] B inhibitor
3383,repaglinide,Peroxisome proliferator-activated receptor gamma inhibitor
3384,repaglinide,Peroxisome proliferator-activated receptor gamma agonist
3392,amantadine,Neuronal acetylcholine receptor subunit alpha-7 antagonist
3394,amantadine,Dopamine D2 receptor inhibitor
3395,amantadine,Dopamine D2 receptor antagonist
3396,amantadine,Dopamine D2 receptor agonist
3397,amantadine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
3398,amantadine,Neuronal acetylcholine receptor subunit alpha-4 antagonist
3399,amantadine,Neuronal acetylcholine receptor subunit alpha-4 agonist
3409,almotriptan,5-hydroxytryptamine receptor 1B agonist
3410,almotriptan,5-hydroxytryptamine receptor 1D agonist
3412,buprenorphine,Mu-type opioid receptor antagonist
3413,buprenorphine,Kappa-type opioid receptor partial agonist
3414,buprenorphine,Kappa-type opioid receptor antagonist
3416,buprenorphine,Delta-type opioid receptor antagonist
3430,levosimendan,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
3431,cyclobenzaprine,5-hydroxytryptamine receptor 2A antagonist
3432,cyclobenzaprine,5-hydroxytryptamine receptor 2A inhibitor
3433,cyclobenzaprine,5-hydroxytryptamine receptor 2B antagonist
3434,cyclobenzaprine,5-hydroxytryptamine receptor 2B inhibitor
3435,cyclobenzaprine,5-hydroxytryptamine receptor 2C antagonist
3436,cyclobenzaprine,5-hydroxytryptamine receptor 2C inhibitor
3437,cyclobenzaprine,5-hydroxytryptamine receptor 6 antagonist
3438,cyclobenzaprine,5-hydroxytryptamine receptor 6 inhibitor
3439,cyclobenzaprine,Sodium-dependent serotonin transporter antagonist
3440,cyclobenzaprine,Sodium-dependent serotonin transporter inhibitor
3441,cyclobenzaprine,Sodium-dependent noradrenaline transporter antagonist
3442,cyclobenzaprine,Sodium-dependent noradrenaline transporter inhibitor
3443,cyclobenzaprine,5-hydroxytryptamine receptor 7 antagonist
3444,cyclobenzaprine,5-hydroxytryptamine receptor 7 inhibitor
3449,phenoxybenzamine,Alpha-1A adrenergic receptor antagonist
3450,phenoxybenzamine,Alpha-1A adrenergic receptor inhibitor
3451,phenoxybenzamine,Alpha-2A adrenergic receptor antagonist
3452,phenoxybenzamine,Alpha-2A adrenergic receptor inhibitor
3453,phenoxybenzamine,Alpha-2C adrenergic receptor antagonist
3454,phenoxybenzamine,Alpha-2C adrenergic receptor inhibitor
3455,phenoxybenzamine,Alpha-2B adrenergic receptor antagonist
3456,phenoxybenzamine,Alpha-2B adrenergic receptor inhibitor
3457,phenoxybenzamine,Calmodulin antagonist
3458,phenoxybenzamine,Calmodulin inhibitor
3459,phenoxybenzamine,Beta-2 adrenergic receptor antagonist
3460,phenoxybenzamine,Beta-2 adrenergic receptor inhibitor
3461,phenoxybenzamine,Alpha-1B adrenergic receptor antagonist
3462,phenoxybenzamine,Alpha-1B adrenergic receptor inhibitor
3463,phenoxybenzamine,Alpha-1D adrenergic receptor antagonist
3464,phenoxybenzamine,Alpha-1D adrenergic receptor inhibitor
3465,famotidine,Histamine H2 receptor antagonist
3471,maprotiline,Sodium-dependent noradrenaline transporter inhibitor
3472,maprotiline,Sodium-dependent noradrenaline transporter antagonist
3473,maprotiline,Sodium-dependent noradrenaline transporter binder
3474,maprotiline,Histamine H1 receptor inhibitor
3475,maprotiline,Histamine H1 receptor antagonist
3476,maprotiline,Histamine H1 receptor binder
3477,maprotiline,Muscarinic acetylcholine receptor M1 inhibitor
3478,maprotiline,Muscarinic acetylcholine receptor M1 antagonist
3479,maprotiline,Muscarinic acetylcholine receptor M1 binder
3480,maprotiline,Muscarinic acetylcholine receptor M2 inhibitor
3481,maprotiline,Muscarinic acetylcholine receptor M2 antagonist
3483,maprotiline,Muscarinic acetylcholine receptor M3 inhibitor
3484,maprotiline,Muscarinic acetylcholine receptor M3 antagonist
3485,maprotiline,Muscarinic acetylcholine receptor M3 binder
3486,maprotiline,Muscarinic acetylcholine receptor M4 inhibitor
3487,maprotiline,Muscarinic acetylcholine receptor M4 antagonist
3489,maprotiline,Muscarinic acetylcholine receptor M5 inhibitor
3490,maprotiline,Muscarinic acetylcholine receptor M5 antagonist
3492,maprotiline,Alpha-1 adrenergic receptors inhibitor
3493,maprotiline,Alpha-1 adrenergic receptors antagonist
3494,maprotiline,Alpha-1 adrenergic receptors binder
3495,maprotiline,5-hydroxytryptamine receptor 2A inhibitor
3496,maprotiline,5-hydroxytryptamine receptor 2A antagonist
3497,maprotiline,5-hydroxytryptamine receptor 2A binder
3498,maprotiline,5-hydroxytryptamine receptor 2C inhibitor
3499,maprotiline,5-hydroxytryptamine receptor 2C antagonist
3500,maprotiline,5-hydroxytryptamine receptor 2C binder
3501,maprotiline,5-hydroxytryptamine receptor 7 inhibitor
3502,maprotiline,5-hydroxytryptamine receptor 7 antagonist
3503,maprotiline,5-hydroxytryptamine receptor 7 binder
3504,maprotiline,Dopamine D2 receptor inhibitor
3505,maprotiline,Dopamine D2 receptor antagonist
3506,maprotiline,Dopamine D2 receptor binder
3507,maprotiline,Alpha-2 adrenergic receptors inhibitor
3508,maprotiline,Alpha-2 adrenergic receptors antagonist
3509,maprotiline,Alpha-2 adrenergic receptors binder
3510,diethylpropion,Sodium-dependent noradrenaline transporter inhibitor
3511,diethylpropion,Sodium-dependent dopamine transporter inhibitor
3512,salmeterol,Beta-2 adrenergic receptor agonist
3513,salmeterol,Beta-1 adrenergic receptor agonist
3514,salmeterol,Beta-3 adrenergic receptor agonist
3515,zalcitabine,Reverse transcriptase/RNaseH inhibitor
3518,fexofenadine,Histamine H1 receptor antagonist
3519,naratriptan,5-hydroxytryptamine receptor 1D agonist
3520,naratriptan,5-hydroxytryptamine receptor 1B agonist
3521,naratriptan,5-hydroxytryptamine receptor 1F agonist
3522,naratriptan,5-hydroxytryptamine receptor 1A agonist
3523,rizatriptan,5-hydroxytryptamine receptor 1D agonist
3524,rizatriptan,5-hydroxytryptamine receptor 1B agonist
3525,rizatriptan,5-hydroxytryptamine receptor 1F agonist
3526,hydrocodone,Mu-type opioid receptor agonist
3528,hydrocodone,Delta-type opioid receptor agonist
3532,methylprednisolone,Glucocorticoid receptor agonist
3534,pindolol,Beta-1 adrenergic receptor partial agonist
3535,pindolol,Beta-1 adrenergic receptor antagonist
3536,pindolol,Beta-1 adrenergic receptor inhibitor
3539,pindolol,Beta-1 adrenergic receptor agonist
3540,pindolol,Beta-2 adrenergic receptor partial agonist
3541,pindolol,Beta-2 adrenergic receptor antagonist
3542,pindolol,Beta-2 adrenergic receptor inhibitor
3545,pindolol,Beta-2 adrenergic receptor agonist
3546,pindolol,5-hydroxytryptamine receptor 1A partial agonist
3547,pindolol,5-hydroxytryptamine receptor 1A antagonist
3548,pindolol,5-hydroxytryptamine receptor 1A inhibitor
3550,pindolol,5-hydroxytryptamine receptor 1A other/unknown
3551,pindolol,5-hydroxytryptamine receptor 1A agonist
3553,pindolol,5-hydroxytryptamine receptor 1B antagonist
3557,pindolol,5-hydroxytryptamine receptor 1B agonist
3559,pindolol,Beta-3 adrenergic receptor antagonist
3563,pindolol,Beta-3 adrenergic receptor agonist
3566,pindolol,Beta adrenergic receptor inhibitor
3570,mepivacaine,Sodium channel protein type 10 subunit alpha inhibitor
3571,zaleplon,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
3572,apraclonidine,Alpha-2A adrenergic receptor agonist
3573,apraclonidine,Alpha-1A adrenergic receptor agonist
3574,apraclonidine,Alpha-2B adrenergic receptor agonist
3575,telmisartan,Type-1 angiotensin II receptor antagonist
3579,desloratadine,Histamine H1 receptor antagonist
3580,methyldopa,Alpha-2A adrenergic receptor agonist
3581,methyldopa,Alpha-2A adrenergic receptor inhibitor
3584,azelastine,Histamine H1 receptor antagonist
3585,azelastine,Histamine H1 receptor inhibitor
3586,azelastine,Histamine H2 receptor antagonist
3594,dipyridamole,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
3599,lomefloxacin,DNA topoisomerase 4 subunit A inhibitor
3600,lomefloxacin,DNA gyrase subunit A inhibitor
3601,lomefloxacin,DNA topoisomerase 2-alpha inhibitor
3602,cyclopentolate,Muscarinic acetylcholine receptor M1 antagonist
3603,physostigmine,Acetylcholinesterase inhibitor
3604,physostigmine,Neuronal acetylcholine receptor subunit alpha-4 inhibitor
3606,formoterol,Beta-2 adrenergic receptor agonist
3607,formoterol,Beta-1 adrenergic receptor agonist
3608,formoterol,Beta-3 adrenergic receptor agonist
3609,dimenhydrinate,Histamine H1 receptor antagonist
3611,cytarabine,DNA inhibitor
3612,dopamine,Dopamine D2 receptor agonist
3615,dopamine,Dopamine D2 receptor binder
3616,dopamine,Dopamine D2 receptor inhibitor
3617,dopamine,Dopamine D1 receptor agonist
3621,dopamine,Dopamine D1 receptor inhibitor
3622,dopamine,Dopamine D5 receptor agonist
3627,dopamine,Dopamine D3 receptor agonist
3630,dopamine,Dopamine D3 receptor binder
3631,dopamine,Dopamine D3 receptor inhibitor
3632,dopamine,Dopamine D4 receptor agonist
3637,dopamine,Sodium-dependent dopamine transporter agonist
3640,dopamine,Sodium-dependent dopamine transporter binder
3641,dopamine,Sodium-dependent dopamine transporter inhibitor
3647,dopamine,5-hydroxytryptamine receptor 1A agonist
3650,dopamine,5-hydroxytryptamine receptor 1A binder
3651,dopamine,5-hydroxytryptamine receptor 1A inhibitor
3652,dopamine,5-hydroxytryptamine receptor 7 agonist
3655,dopamine,5-hydroxytryptamine receptor 7 binder
3656,dopamine,5-hydroxytryptamine receptor 7 inhibitor
3657,dopamine,D(1) dopamine receptor agonist
3660,dopamine,D(1) dopamine receptor binder
3661,dopamine,D(1) dopamine receptor inhibitor
3662,dopamine,Sodium-dependent noradrenaline transporter agonist
3665,dopamine,Sodium-dependent noradrenaline transporter binder
3666,dopamine,Sodium-dependent noradrenaline transporter inhibitor
3667,dopamine,Sodium-dependent serotonin transporter agonist
3670,dopamine,Sodium-dependent serotonin transporter binder
3671,dopamine,Sodium-dependent serotonin transporter inhibitor
3672,dopamine,5-hydroxytryptamine receptor 3A agonist
3675,dopamine,5-hydroxytryptamine receptor 3A binder
3676,dopamine,5-hydroxytryptamine receptor 3A inhibitor
3691,dopamine,Synaptic vesicular amine transporter inhibitor
3692,rivastigmine,Acetylcholinesterase inhibitor
3693,rivastigmine,Cholinesterase inhibitor
3695,oxaprozin,Prostaglandin G/H synthase 1 inhibitor
3696,oxaprozin,Prostaglandin G/H synthase 2 inhibitor
3697,gabapentin,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
3706,gabapentin,Adenosine receptor A1 inhibitor
3715,doxorubicin,DNA inhibitor
3716,doxorubicin,DNA topoisomerase 2-alpha inhibitor
3718,frovatriptan,5-hydroxytryptamine receptor 1D agonist
3719,frovatriptan,5-hydroxytryptamine receptor 1B agonist
3722,salbutamol,Beta-2 adrenergic receptor agonist
3723,salbutamol,Beta-1 adrenergic receptor agonist
3724,salbutamol,Beta-3 adrenergic receptor agonist
3725,ganciclovir,DNA polymerase catalytic subunit inhibitor
3727,ganciclovir,DNA inhibitor
3732,ketoprofen,Prostaglandin G/H synthase 1 inhibitor
3733,ketoprofen,Prostaglandin G/H synthase 2 inhibitor
3735,edrophonium,Acetylcholinesterase inhibitor
3736,edrophonium,Cholinesterase inhibitor
3738,balsalazide,Peroxisome proliferator-activated receptor gamma agonist
3739,balsalazide,Peroxisome proliferator-activated receptor gamma inhibitor
3741,balsalazide,Prostaglandin G/H synthase 2 inhibitor
3743,balsalazide,Prostaglandin G/H synthase 1 inhibitor
3759,guanfacine,Alpha-2A adrenergic receptor agonist
3760,guanfacine,Alpha-2A adrenergic receptor binder
3761,guanfacine,Alpha-2B adrenergic receptor agonist
3762,guanfacine,Alpha-2B adrenergic receptor binder
3763,bethanechol,Muscarinic acetylcholine receptor M3 agonist
3764,bethanechol,Muscarinic acetylcholine receptor M1 agonist
3768,felodipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
3770,felodipine,Voltage-dependent calcium channel subunit alpha-2/delta-1 inhibitor
3772,felodipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
3774,felodipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
3776,felodipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
3782,felodipine,Calmodulin inhibitor
3783,felodipine,Calmodulin antagonist
3797,ketoconazole,Androgen receptor inhibitor
3799,ketoconazole,Androgen receptor antagonist
3806,ketoconazole,Potassium voltage-gated channel subfamily H member 2 inhibitor
3807,ketoconazole,Potassium voltage-gated channel subfamily H member 2 binder
3808,ketoconazole,Potassium voltage-gated channel subfamily H member 2 antagonist
3809,ketoconazole,Nuclear receptor subfamily 1 group I member 2 inhibitor
3815,irbesartan,Type-1 angiotensin II receptor antagonist
3821,topotecan,DNA inhibitor
3822,procainamide,Sodium channel protein type 5 subunit alpha inhibitor
3824,procainamide,Potassium voltage-gated channel subfamily H member 2 inhibitor
3825,tolterodine,Muscarinic acetylcholine receptor M3 antagonist
3826,tolterodine,Muscarinic acetylcholine receptor M2 antagonist
3827,tolterodine,Muscarinic acetylcholine receptor M5 antagonist
3828,tolterodine,Muscarinic acetylcholine receptor M1 antagonist
3829,tolterodine,Muscarinic acetylcholine receptor M4 antagonist
3830,fenofibrate,Peroxisome proliferator-activated receptor alpha agonist
3831,fenofibrate,Peroxisome proliferator-activated receptor alpha inhibitor
3836,fenofibrate,Nuclear receptor subfamily 1 group I member 2 agonist
3837,fenofibrate,Nuclear receptor subfamily 1 group I member 2 inhibitor
3848,thalidomide,DNA inhibitor
3854,thalidomide,Prostaglandin G/H synthase 2 inhibitor
3860,memantine,5-hydroxytryptamine receptor 3A antagonist
3861,memantine,5-hydroxytryptamine receptor 3A agonist
3862,memantine,5-hydroxytryptamine receptor 3A binder
3863,memantine,5-hydroxytryptamine receptor 3A inhibitor
3868,memantine,Dopamine D2 receptor antagonist
3869,memantine,Dopamine D2 receptor agonist
3870,memantine,Dopamine D2 receptor binder
3871,memantine,Dopamine D2 receptor inhibitor
3880,memantine,GABA(A) Receptor antagonist
3881,memantine,GABA(A) Receptor agonist
3883,memantine,GABA(A) Receptor inhibitor
3888,gatifloxacin,DNA gyrase subunit A inhibitor
3890,gatifloxacin,DNA topoisomerase 4 subunit A inhibitor
3893,abacavir,Reverse transcriptase/RNaseH inhibitor
3895,ibuprofen,Prostaglandin G/H synthase 2 inhibitor
3899,ibuprofen,Prostaglandin G/H synthase 1 inhibitor
3915,ibuprofen,Peroxisome proliferator-activated receptor gamma inhibitor
3923,ibuprofen,Peroxisome proliferator-activated receptor alpha inhibitor
3936,norfloxacin,DNA topoisomerase 4 subunit A inhibitor
3937,norfloxacin,DNA gyrase subunit A inhibitor
3938,norfloxacin,DNA topoisomerase 2-alpha inhibitor
3939,oxybutynin,Muscarinic acetylcholine receptor M3 antagonist
3940,oxybutynin,Muscarinic acetylcholine receptor M2 antagonist
3941,oxybutynin,Muscarinic acetylcholine receptor M1 antagonist
3948,melatonin,Estrogen receptor alpha agonist
3949,melatonin,Estrogen receptor alpha antagonist
3950,melatonin,Estrogen receptor alpha inhibitor
3955,melatonin,Calmodulin antagonist
3956,melatonin,Calmodulin inhibitor
3972,clonazepam,GABA(A) Receptor ligand
3974,clonazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
3978,promethazine,Histamine H1 receptor antagonist
3979,promethazine,Histamine H1 receptor inhibitor
3981,promethazine,Dopamine D2 receptor antagonist
3982,promethazine,Dopamine D2 receptor inhibitor
3984,promethazine,Muscarinic acetylcholine receptor M1 antagonist
3985,promethazine,Muscarinic acetylcholine receptor M1 inhibitor
3987,promethazine,Muscarinic acetylcholine receptor M2 antagonist
3988,promethazine,Muscarinic acetylcholine receptor M2 inhibitor
3990,promethazine,Muscarinic acetylcholine receptor M3 antagonist
3991,promethazine,Muscarinic acetylcholine receptor M3 inhibitor
3993,promethazine,Muscarinic acetylcholine receptor M4 antagonist
3994,promethazine,Muscarinic acetylcholine receptor M4 inhibitor
3996,promethazine,Muscarinic acetylcholine receptor M5 antagonist
3997,promethazine,Muscarinic acetylcholine receptor M5 inhibitor
4002,promethazine,Calmodulin antagonist
4003,promethazine,Calmodulin inhibitor
4005,promethazine,Histamine H2 receptor antagonist
4017,atazanavir,Human immunodeficiency virus type 1 protease inhibitor
4022,fludarabine,DNA inhibitor
4026,diphenhydramine,Histamine H1 receptor antagonist
4027,diphenhydramine,Muscarinic acetylcholine receptor M2 antagonist
4030,tegaserod,5-hydroxytryptamine receptor 2B antagonist
4032,tegaserod,5-hydroxytryptamine receptor 2C antagonist
4034,tegaserod,5-hydroxytryptamine receptor 2A antagonist
4039,emedastine,Histamine H1 receptor antagonist
4040,pilocarpine,Muscarinic acetylcholine receptor M3 agonist
4042,pilocarpine,Muscarinic acetylcholine receptor M1 agonist
4073,fluvastatin,Histone deacetylase 2 inhibitor
4083,pimozide,Dopamine D2 receptor antagonist
4084,pimozide,Dopamine D2 receptor inhibitor
4085,pimozide,Dopamine D3 receptor antagonist
4086,pimozide,Dopamine D3 receptor inhibitor
4087,pimozide,Potassium voltage-gated channel subfamily H member 2 antagonist
4088,pimozide,Potassium voltage-gated channel subfamily H member 2 inhibitor
4089,pimozide,Calmodulin antagonist
4090,pimozide,Calmodulin inhibitor
4091,capecitabine,Thymidylate synthase inhibitor
4092,capecitabine,DNA inhibitor
4094,sertraline,Sodium-dependent serotonin transporter inhibitor
4095,sertraline,Sodium-dependent serotonin transporter binder
4096,sertraline,Sodium-dependent dopamine transporter inhibitor
4097,sertraline,Sodium-dependent dopamine transporter binder
4100,sertraline,Sodium-dependent noradrenaline transporter inhibitor
4101,sertraline,Sodium-dependent noradrenaline transporter binder
4104,sibutramine,Sodium-dependent noradrenaline transporter inhibitor
4105,sibutramine,Sodium-dependent serotonin transporter inhibitor
4106,sibutramine,Sodium-dependent dopamine transporter inhibitor
4132,chlorpheniramine,Histamine H1 receptor antagonist
4133,chlorpheniramine,Histamine H1 receptor inhibitor
4134,chlorpheniramine,Sodium-dependent serotonin transporter antagonist
4135,chlorpheniramine,Sodium-dependent serotonin transporter inhibitor
4136,chlorpheniramine,Sodium-dependent noradrenaline transporter antagonist
4137,chlorpheniramine,Sodium-dependent noradrenaline transporter inhibitor
4138,chlorpheniramine,Sodium-dependent dopamine transporter antagonist
4139,chlorpheniramine,Sodium-dependent dopamine transporter inhibitor
4140,nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
4142,nifedipine,Nuclear receptor subfamily 1 group I member 2 inhibitor
4143,nifedipine,Nuclear receptor subfamily 1 group I member 2 agonist
4144,nifedipine,Calmodulin inhibitor
4146,nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
4148,nifedipine,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
4150,nifedipine,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
4160,amiodarone,Beta adrenergic receptor inhibitor
4176,amiodarone,Peroxisome proliferator-activated receptor gamma inhibitor
4179,amiodarone,Peroxisome proliferator-activated receptor gamma agonist
4180,amiodarone,Peroxisome proliferator-activated receptor alpha inhibitor
4183,amiodarone,Peroxisome proliferator-activated receptor alpha agonist
4191,diazoxide,Carbonic anhydrase 1 inhibitor
4193,diazoxide,Carbonic anhydrase 2 inhibitor
4204,bicalutamide,Androgen receptor antagonist
4206,pioglitazone,Peroxisome proliferator-activated receptor gamma agonist
4207,pioglitazone,Peroxisome proliferator-activated receptor gamma inhibitor
4209,pioglitazone,Amine oxidase [flavin-containing] B inhibitor
4210,carvedilol,Beta-1 adrenergic receptor antagonist
4212,carvedilol,Beta-1 adrenergic receptor inhibitor
4213,carvedilol,Alpha-1A adrenergic receptor antagonist
4215,carvedilol,Alpha-1A adrenergic receptor inhibitor
4219,carvedilol,Beta-2 adrenergic receptor antagonist
4221,carvedilol,Beta-2 adrenergic receptor inhibitor
4231,carvedilol,Potassium voltage-gated channel subfamily H member 2 antagonist
4233,carvedilol,Potassium voltage-gated channel subfamily H member 2 inhibitor
4237,carvedilol,Alpha-1D adrenergic receptor antagonist
4239,carvedilol,Alpha-1D adrenergic receptor inhibitor
4240,carvedilol,Alpha-1B adrenergic receptor antagonist
4242,carvedilol,Alpha-1B adrenergic receptor inhibitor
4243,carvedilol,Alpha-2C adrenergic receptor antagonist
4245,carvedilol,Alpha-2C adrenergic receptor inhibitor
4246,carvedilol,Alpha-2B adrenergic receptor antagonist
4248,carvedilol,Alpha-2B adrenergic receptor inhibitor
4249,carvedilol,Alpha-2A adrenergic receptor antagonist
4251,carvedilol,Alpha-2A adrenergic receptor inhibitor
4264,carvedilol,Alpha-1 adrenergic receptors antagonist
4266,carvedilol,Alpha-1 adrenergic receptors inhibitor
4267,doxepin,Histamine H1 receptor antagonist
4268,doxepin,Histamine H1 receptor inhibitor
4269,doxepin,Histamine H1 receptor binder
4270,doxepin,Histamine H2 receptor antagonist
4273,doxepin,Sodium-dependent noradrenaline transporter antagonist
4274,doxepin,Sodium-dependent noradrenaline transporter inhibitor
4275,doxepin,Sodium-dependent noradrenaline transporter binder
4276,doxepin,Sodium-dependent serotonin transporter antagonist
4277,doxepin,Sodium-dependent serotonin transporter inhibitor
4278,doxepin,Sodium-dependent serotonin transporter binder
4279,doxepin,5-hydroxytryptamine receptor 2A antagonist
4280,doxepin,5-hydroxytryptamine receptor 2A inhibitor
4281,doxepin,5-hydroxytryptamine receptor 2A binder
4282,doxepin,5-hydroxytryptamine receptor 2B antagonist
4283,doxepin,5-hydroxytryptamine receptor 2B inhibitor
4284,doxepin,5-hydroxytryptamine receptor 2B binder
4285,doxepin,5-hydroxytryptamine receptor 2C antagonist
4286,doxepin,5-hydroxytryptamine receptor 2C inhibitor
4287,doxepin,5-hydroxytryptamine receptor 2C binder
4288,doxepin,Muscarinic acetylcholine receptor M1 antagonist
4289,doxepin,Muscarinic acetylcholine receptor M1 inhibitor
4290,doxepin,Muscarinic acetylcholine receptor M1 binder
4291,doxepin,Muscarinic acetylcholine receptor M2 antagonist
4292,doxepin,Muscarinic acetylcholine receptor M2 inhibitor
4294,doxepin,Muscarinic acetylcholine receptor M3 antagonist
4295,doxepin,Muscarinic acetylcholine receptor M3 inhibitor
4296,doxepin,Muscarinic acetylcholine receptor M3 binder
4297,doxepin,Muscarinic acetylcholine receptor M4 antagonist
4298,doxepin,Muscarinic acetylcholine receptor M4 inhibitor
4300,doxepin,Muscarinic acetylcholine receptor M5 antagonist
4301,doxepin,Muscarinic acetylcholine receptor M5 inhibitor
4303,doxepin,Alpha-1A adrenergic receptor antagonist
4304,doxepin,Alpha-1A adrenergic receptor inhibitor
4305,doxepin,Alpha-1A adrenergic receptor binder
4306,doxepin,Alpha-1B adrenergic receptor antagonist
4307,doxepin,Alpha-1B adrenergic receptor inhibitor
4308,doxepin,Alpha-1B adrenergic receptor binder
4309,doxepin,Alpha-1D adrenergic receptor antagonist
4310,doxepin,Alpha-1D adrenergic receptor inhibitor
4311,doxepin,Alpha-1D adrenergic receptor binder
4312,doxepin,5-hydroxytryptamine receptor 1A antagonist
4313,doxepin,5-hydroxytryptamine receptor 1A inhibitor
4314,doxepin,5-hydroxytryptamine receptor 1A binder
4315,doxepin,5-hydroxytryptamine receptor 6 antagonist
4316,doxepin,5-hydroxytryptamine receptor 6 inhibitor
4317,doxepin,5-hydroxytryptamine receptor 6 binder
4318,doxepin,Histamine H4 receptor antagonist
4320,doxepin,Histamine H4 receptor binder
4321,doxepin,Potassium voltage-gated channel subfamily H member 2 antagonist
4322,doxepin,Potassium voltage-gated channel subfamily H member 2 inhibitor
4323,doxepin,Potassium voltage-gated channel subfamily H member 2 binder
4325,flavoxate,Muscarinic acetylcholine receptor M2 antagonist
4326,flavoxate,Muscarinic acetylcholine receptor M1 antagonist
4327,nefazodone,5-hydroxytryptamine receptor 2A antagonist
4328,nefazodone,5-hydroxytryptamine receptor 2A inhibitor
4329,nefazodone,5-hydroxytryptamine receptor 2A other/unknown
4330,nefazodone,5-hydroxytryptamine receptor 2C antagonist
4331,nefazodone,5-hydroxytryptamine receptor 2C inhibitor
4333,nefazodone,Sodium-dependent serotonin transporter antagonist
4334,nefazodone,Sodium-dependent serotonin transporter inhibitor
4336,nefazodone,5-hydroxytryptamine receptor 1A antagonist
4337,nefazodone,5-hydroxytryptamine receptor 1A inhibitor
4338,nefazodone,5-hydroxytryptamine receptor 1A other/unknown
4339,nefazodone,Sodium-dependent noradrenaline transporter antagonist
4340,nefazodone,Sodium-dependent noradrenaline transporter inhibitor
4342,nefazodone,Sodium-dependent dopamine transporter antagonist
4343,nefazodone,Sodium-dependent dopamine transporter inhibitor
4345,nefazodone,Alpha-1B adrenergic receptor antagonist
4346,nefazodone,Alpha-1B adrenergic receptor inhibitor
4348,nefazodone,Alpha-2A adrenergic receptor antagonist
4349,nefazodone,Alpha-2A adrenergic receptor inhibitor
4351,nefazodone,Alpha-1A adrenergic receptor antagonist
4352,nefazodone,Alpha-1A adrenergic receptor inhibitor
4354,nefazodone,Potassium voltage-gated channel subfamily H member 2 antagonist
4355,nefazodone,Potassium voltage-gated channel subfamily H member 2 inhibitor
4357,desipramine,Sodium-dependent noradrenaline transporter inhibitor
4358,desipramine,Sodium-dependent noradrenaline transporter antagonist
4359,desipramine,Sodium-dependent noradrenaline transporter binder
4360,desipramine,Beta-2 adrenergic receptor inhibitor
4361,desipramine,Beta-2 adrenergic receptor antagonist
4363,desipramine,Sodium-dependent serotonin transporter inhibitor
4364,desipramine,Sodium-dependent serotonin transporter antagonist
4365,desipramine,Sodium-dependent serotonin transporter binder
4366,desipramine,5-hydroxytryptamine receptor 2A inhibitor
4367,desipramine,5-hydroxytryptamine receptor 2A antagonist
4368,desipramine,5-hydroxytryptamine receptor 2A binder
4369,desipramine,Beta-1 adrenergic receptor inhibitor
4370,desipramine,Beta-1 adrenergic receptor antagonist
4375,desipramine,Histamine H1 receptor inhibitor
4376,desipramine,Histamine H1 receptor antagonist
4377,desipramine,Histamine H1 receptor binder
4378,desipramine,Alpha-1 adrenergic receptors inhibitor
4379,desipramine,Alpha-1 adrenergic receptors antagonist
4380,desipramine,Alpha-1 adrenergic receptors binder
4381,desipramine,Muscarinic acetylcholine receptor M1 inhibitor
4382,desipramine,Muscarinic acetylcholine receptor M1 antagonist
4383,desipramine,Muscarinic acetylcholine receptor M1 binder
4384,desipramine,Muscarinic acetylcholine receptor M2 inhibitor
4385,desipramine,Muscarinic acetylcholine receptor M2 antagonist
4387,desipramine,Muscarinic acetylcholine receptor M3 inhibitor
4388,desipramine,Muscarinic acetylcholine receptor M3 antagonist
4389,desipramine,Muscarinic acetylcholine receptor M3 binder
4390,desipramine,Muscarinic acetylcholine receptor M4 inhibitor
4391,desipramine,Muscarinic acetylcholine receptor M4 antagonist
4393,desipramine,Muscarinic acetylcholine receptor M5 inhibitor
4394,desipramine,Muscarinic acetylcholine receptor M5 antagonist
4396,desipramine,5-hydroxytryptamine receptor 1A inhibitor
4397,desipramine,5-hydroxytryptamine receptor 1A antagonist
4398,desipramine,5-hydroxytryptamine receptor 1A binder
4399,desipramine,5-hydroxytryptamine receptor 2C inhibitor
4400,desipramine,5-hydroxytryptamine receptor 2C antagonist
4401,desipramine,5-hydroxytryptamine receptor 2C binder
4402,desipramine,Dopamine D2 receptor inhibitor
4403,desipramine,Dopamine D2 receptor antagonist
4404,desipramine,Dopamine D2 receptor binder
4405,desipramine,Alpha-2 adrenergic receptors inhibitor
4406,desipramine,Alpha-2 adrenergic receptors antagonist
4407,desipramine,Alpha-2 adrenergic receptors binder
4408,gemifloxacin,DNA topoisomerase 4 subunit A inhibitor
4409,gemifloxacin,DNA gyrase subunit A inhibitor
4410,bupropion,Sodium-dependent dopamine transporter inhibitor
4411,bupropion,Sodium-dependent dopamine transporter antagonist
4412,bupropion,Sodium-dependent noradrenaline transporter inhibitor
4413,bupropion,Sodium-dependent noradrenaline transporter antagonist
4416,bupropion,5-hydroxytryptamine receptor 3A inhibitor
4417,bupropion,5-hydroxytryptamine receptor 3A antagonist
4419,chloroprocaine,Sodium channel protein type 10 subunit alpha inhibitor
4420,chloroprocaine,Sodium-dependent dopamine transporter inhibitor
4421,terazosin,Alpha-1A adrenergic receptor antagonist
4422,terazosin,Alpha-1A adrenergic receptor inhibitor
4424,terazosin,Alpha-1B adrenergic receptor antagonist
4425,terazosin,Alpha-1B adrenergic receptor inhibitor
4427,terazosin,Alpha-1D adrenergic receptor antagonist
4428,terazosin,Alpha-1D adrenergic receptor inhibitor
4430,terazosin,Potassium voltage-gated channel subfamily H member 2 antagonist
4431,terazosin,Potassium voltage-gated channel subfamily H member 2 inhibitor
4442,ofloxacin,DNA topoisomerase 4 subunit A inhibitor
4443,ofloxacin,DNA gyrase subunit A inhibitor
4444,ofloxacin,DNA topoisomerase 2-alpha inhibitor
4445,cilostazol,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
4448,procarbazine,DNA inhibitor
4455,moclobemide,Amine oxidase [flavin-containing] B inhibitor
4464,orphenadrine,Histamine H1 receptor antagonist
4465,orphenadrine,Histamine H1 receptor inhibitor
4466,orphenadrine,Sodium-dependent noradrenaline transporter antagonist
4467,orphenadrine,Sodium-dependent noradrenaline transporter inhibitor
4469,orphenadrine,Sodium channel protein type 10 subunit alpha inhibitor
4470,phenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
4471,phenobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
4474,phenobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
4477,phenobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
4491,cyclizine,Histamine H1 receptor antagonist
4492,cyclizine,Histamine H1 receptor inhibitor
4495,idarubicin,DNA inhibitor
4496,idarubicin,DNA topoisomerase 2-alpha inhibitor
4497,rescinnamine,Angiotensin-converting enzyme inhibitor
4500,propafenone,Sodium channel protein type 5 subunit alpha inhibitor
4502,propafenone,Potassium voltage-gated channel subfamily H member 2 inhibitor
4503,propafenone,Potassium voltage-gated channel subfamily H member 2 antagonist
4504,propafenone,Beta-1 adrenergic receptor inhibitor
4505,propafenone,Beta-1 adrenergic receptor antagonist
4506,propafenone,Beta-2 adrenergic receptor inhibitor
4507,propafenone,Beta-2 adrenergic receptor antagonist
4508,naloxone,Mu-type opioid receptor antagonist
4510,naloxone,Mu-type opioid receptor inhibitor
4512,naloxone,Delta-type opioid receptor antagonist
4516,naloxone,Kappa-type opioid receptor antagonist
4518,naloxone,Kappa-type opioid receptor inhibitor
4519,naloxone,Kappa-type opioid receptor binder
4524,naloxone,Estrogen receptor alpha antagonist
4526,naloxone,Estrogen receptor alpha inhibitor
4536,pergolide,Dopamine D2 receptor agonist
4537,pergolide,Dopamine D3 receptor agonist
4538,pergolide,Dopamine D4 receptor agonist
4539,pergolide,5-hydroxytryptamine receptor 1A agonist
4540,pergolide,5-hydroxytryptamine receptor 2B agonist
4541,pergolide,5-hydroxytryptamine receptor 2A agonist
4542,pergolide,5-hydroxytryptamine receptor 1D agonist
4543,pergolide,Alpha-2 adrenergic receptors agonist
4544,pergolide,Dopamine D5 receptor agonist
4545,pergolide,Dopamine D1 receptor agonist
4546,pergolide,5-hydroxytryptamine receptor 1B agonist
4547,pergolide,5-hydroxytryptamine receptor 2C agonist
4548,pergolide,Alpha-1A adrenergic receptor agonist
4549,pergolide,Alpha-1B adrenergic receptor agonist
4550,pergolide,Alpha-1D adrenergic receptor agonist
4552,desflurane,GABA(A) Receptor agonist
4553,desflurane,GABA(A) Receptor antagonist
4556,desflurane,GABA(A) Receptor inhibitor
4588,oxymorphone,Mu-type opioid receptor agonist
4589,oxymorphone,Mu-type opioid receptor antagonist
4590,oxymorphone,Delta-type opioid receptor agonist
4591,oxymorphone,Delta-type opioid receptor antagonist
4592,acebutolol,Beta-1 adrenergic receptor partial agonist
4593,acebutolol,Beta-2 adrenergic receptor partial agonist
4594,brinzolamide,Carbonic anhydrase 2 inhibitor
4595,brinzolamide,Carbonic anhydrase 1 inhibitor
4598,brinzolamide,Carbonic anhydrase 3 inhibitor
4599,flecainide,Sodium channel protein type 5 subunit alpha inhibitor
4601,flecainide,Potassium voltage-gated channel subfamily H member 2 inhibitor
4609,estramustine,Estrogen receptor alpha antagonist
4610,estramustine,Estrogen receptor alpha agonist
4613,estramustine,Estrogen receptor beta agonist
4615,captopril,Angiotensin-converting enzyme inhibitor
4620,zopiclone,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
4621,zopiclone,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
4630,bromocriptine,Dopamine D2 receptor agonist
4631,bromocriptine,Dopamine D2 receptor antagonist
4632,bromocriptine,Dopamine D3 receptor agonist
4633,bromocriptine,Dopamine D3 receptor antagonist
4634,bromocriptine,5-hydroxytryptamine receptor 1D agonist
4635,bromocriptine,5-hydroxytryptamine receptor 1D antagonist
4636,bromocriptine,Alpha-2A adrenergic receptor agonist
4637,bromocriptine,Alpha-2A adrenergic receptor antagonist
4638,bromocriptine,5-hydroxytryptamine receptor 1A agonist
4639,bromocriptine,5-hydroxytryptamine receptor 1A antagonist
4640,bromocriptine,Alpha-2C adrenergic receptor agonist
4641,bromocriptine,Alpha-2C adrenergic receptor antagonist
4642,bromocriptine,Alpha-2B adrenergic receptor agonist
4643,bromocriptine,Alpha-2B adrenergic receptor antagonist
4644,bromocriptine,5-hydroxytryptamine receptor 2B agonist
4645,bromocriptine,5-hydroxytryptamine receptor 2B antagonist
4646,bromocriptine,Dopamine D4 receptor agonist
4647,bromocriptine,Dopamine D4 receptor antagonist
4648,bromocriptine,5-hydroxytryptamine receptor 2A agonist
4649,bromocriptine,5-hydroxytryptamine receptor 2A antagonist
4650,bromocriptine,5-hydroxytryptamine receptor 1B agonist
4651,bromocriptine,5-hydroxytryptamine receptor 1B antagonist
4652,bromocriptine,5-hydroxytryptamine receptor 2C agonist
4653,bromocriptine,5-hydroxytryptamine receptor 2C antagonist
4654,bromocriptine,Dopamine D5 receptor agonist
4655,bromocriptine,Dopamine D5 receptor antagonist
4656,bromocriptine,Dopamine D1 receptor agonist
4657,bromocriptine,Dopamine D1 receptor antagonist
4658,bromocriptine,Alpha-1A adrenergic receptor agonist
4659,bromocriptine,Alpha-1A adrenergic receptor antagonist
4660,bromocriptine,Alpha-1B adrenergic receptor agonist
4661,bromocriptine,Alpha-1B adrenergic receptor antagonist
4662,bromocriptine,Alpha-1D adrenergic receptor agonist
4663,bromocriptine,Alpha-1D adrenergic receptor antagonist
4664,bromocriptine,5-hydroxytryptamine receptor 7 agonist
4665,bromocriptine,5-hydroxytryptamine receptor 7 antagonist
4667,nadolol,Beta-1 adrenergic receptor antagonist
4668,nadolol,Beta-2 adrenergic receptor antagonist
4669,mitoxantrone,DNA inhibitor
4670,mitoxantrone,DNA topoisomerase 2-alpha inhibitor
4671,flumazenil,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
4674,flumazenil,GABA(A) Receptor antagonist
4675,sparfloxacin,DNA topoisomerase 4 subunit A inhibitor
4676,sparfloxacin,DNA gyrase subunit A inhibitor
4677,sparfloxacin,DNA topoisomerase 2-alpha inhibitor
4678,levobunolol,Beta-2 adrenergic receptor antagonist
4679,levobunolol,Beta-1 adrenergic receptor antagonist
4681,clarithromycin,Potassium voltage-gated channel subfamily H member 2 inhibitor
4684,metipranolol,Beta-2 adrenergic receptor antagonist
4685,metipranolol,Beta-1 adrenergic receptor antagonist
4700,ketamine,Dopamine D2 receptor antagonist
4701,ketamine,Dopamine D2 receptor agonist
4703,ketamine,Dopamine D2 receptor binder
4704,ketamine,Dopamine D2 receptor inhibitor
4706,ketamine,Delta-type opioid receptor antagonist
4707,ketamine,Delta-type opioid receptor agonist
4712,ketamine,Sodium-dependent noradrenaline transporter antagonist
4713,ketamine,Sodium-dependent noradrenaline transporter agonist
4715,ketamine,Sodium-dependent noradrenaline transporter binder
4716,ketamine,Sodium-dependent noradrenaline transporter inhibitor
4718,ketamine,Kappa-type opioid receptor antagonist
4719,ketamine,Kappa-type opioid receptor agonist
4720,ketamine,Kappa-type opioid receptor partial agonist
4721,ketamine,Kappa-type opioid receptor binder
4722,ketamine,Kappa-type opioid receptor inhibitor
4724,ketamine,Mu-type opioid receptor antagonist
4725,ketamine,Mu-type opioid receptor agonist
4728,ketamine,Mu-type opioid receptor inhibitor
4730,ketamine,Muscarinic acetylcholine receptor antagonist
4733,ketamine,Muscarinic acetylcholine receptor binder
4734,ketamine,Muscarinic acetylcholine receptor inhibitor
4748,ketamine,5-hydroxytryptamine receptor 3A antagonist
4749,ketamine,5-hydroxytryptamine receptor 3A agonist
4751,ketamine,5-hydroxytryptamine receptor 3A binder
4752,ketamine,5-hydroxytryptamine receptor 3A inhibitor
4764,ketamine,Cholinesterase inhibitor
4772,budesonide,Glucocorticoid receptor agonist
4774,aminophylline,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A inhibitor"
4777,aminophylline,Adenosine receptor A1 inhibitor
4778,aminophylline,Adenosine receptor A1 antagonist
4783,aminophylline,Histone deacetylase 2 inhibitor
4786,quetiapine,5-hydroxytryptamine receptor 2A antagonist
4789,quetiapine,Dopamine D2 receptor antagonist
4792,quetiapine,5-hydroxytryptamine receptor 1A antagonist
4793,quetiapine,5-hydroxytryptamine receptor 1A partial agonist
4795,quetiapine,5-hydroxytryptamine receptor 1B antagonist
4798,quetiapine,5-hydroxytryptamine receptor 1D antagonist
4801,quetiapine,5-hydroxytryptamine receptor 1E antagonist
4804,quetiapine,5-hydroxytryptamine receptor 2C antagonist
4807,quetiapine,5-hydroxytryptamine receptor 3A antagonist
4810,quetiapine,5-hydroxytryptamine receptor 6 antagonist
4813,quetiapine,5-hydroxytryptamine receptor 7 antagonist
4816,quetiapine,Dopamine D1 receptor antagonist
4819,quetiapine,Dopamine D5 receptor antagonist
4822,quetiapine,Dopamine D3 receptor antagonist
4825,quetiapine,Dopamine D4 receptor antagonist
4828,quetiapine,Histamine H1 receptor antagonist
4831,quetiapine,Alpha-1 adrenergic receptors antagonist
4834,quetiapine,Alpha-2A adrenergic receptor antagonist
4837,quetiapine,Alpha-2B adrenergic receptor antagonist
4840,quetiapine,Alpha-2C adrenergic receptor antagonist
4843,quetiapine,Muscarinic acetylcholine receptor M1 antagonist
4846,quetiapine,Muscarinic acetylcholine receptor M2 antagonist
4849,quetiapine,Muscarinic acetylcholine receptor M3 antagonist
4852,quetiapine,Muscarinic acetylcholine receptor M4 antagonist
4855,quetiapine,Muscarinic acetylcholine receptor M5 antagonist
4858,mivacurium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
4860,mivacurium,Muscarinic acetylcholine receptor M2 antagonist
4862,mivacurium,Muscarinic acetylcholine receptor M3 antagonist
4876,paclitaxel,Nuclear receptor subfamily 1 group I member 2 inhibitor
4878,saquinavir,Human immunodeficiency virus type 1 protease inhibitor
4879,metoclopramide,Dopamine D2 receptor antagonist
4880,metoclopramide,Dopamine D2 receptor agonist
4881,metoclopramide,Muscarinic acetylcholine receptor M1 antagonist
4882,metoclopramide,Muscarinic acetylcholine receptor M1 agonist
4885,metoclopramide,5-hydroxytryptamine receptor 3A antagonist
4886,metoclopramide,5-hydroxytryptamine receptor 3A agonist
4887,dexamethasone,Glucocorticoid receptor agonist
4891,dexamethasone,Nuclear receptor subfamily 1 group I member 2 agonist
4892,sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 agonist
4893,sevoflurane,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
4912,sevoflurane,GABA(A) Receptor agonist
4913,sevoflurane,GABA(A) Receptor antagonist
4914,sevoflurane,GABA(A) Receptor inhibitor
4920,aripiprazole,5-hydroxytryptamine receptor 1A partial agonist
4921,aripiprazole,5-hydroxytryptamine receptor 1A antagonist
4923,aripiprazole,5-hydroxytryptamine receptor 1A other/unknown
4925,aripiprazole,Dopamine D2 receptor antagonist
4927,aripiprazole,Dopamine D2 receptor other/unknown
4929,aripiprazole,5-hydroxytryptamine receptor 2A antagonist
4931,aripiprazole,5-hydroxytryptamine receptor 2A other/unknown
4933,aripiprazole,Alpha-1A adrenergic receptor antagonist
4937,aripiprazole,Alpha-1B adrenergic receptor antagonist
4941,aripiprazole,Dopamine D3 receptor antagonist
4945,aripiprazole,5-hydroxytryptamine receptor 1D antagonist
4949,aripiprazole,5-hydroxytryptamine receptor 7 antagonist
4953,aripiprazole,Alpha-2A adrenergic receptor antagonist
4957,aripiprazole,Alpha-2C adrenergic receptor antagonist
4961,aripiprazole,Histamine H1 receptor antagonist
4965,aripiprazole,5-hydroxytryptamine receptor 1B antagonist
4969,aripiprazole,5-hydroxytryptamine receptor 2C antagonist
4973,aripiprazole,5-hydroxytryptamine receptor 3A antagonist
4977,aripiprazole,5-hydroxytryptamine receptor 6 antagonist
4981,aripiprazole,Dopamine D1 receptor antagonist
4985,aripiprazole,Dopamine D4 receptor antagonist
4989,aripiprazole,Alpha-2B adrenergic receptor antagonist
4993,aripiprazole,5-hydroxytryptamine receptor 1E antagonist
4997,aripiprazole,Dopamine D5 receptor antagonist
5001,aripiprazole,5-hydroxytryptamine receptor 2B antagonist
5008,aripiprazole,Beta-1 adrenergic receptor partial agonist
5009,aripiprazole,Beta-1 adrenergic receptor antagonist
5012,aripiprazole,Beta-2 adrenergic receptor partial agonist
5013,aripiprazole,Beta-2 adrenergic receptor antagonist
5017,aripiprazole,Histamine H2 receptor antagonist
5025,aripiprazole,Histamine H4 receptor antagonist
5029,aripiprazole,Muscarinic acetylcholine receptor M1 antagonist
5033,aripiprazole,Muscarinic acetylcholine receptor M2 antagonist
5037,aripiprazole,Muscarinic acetylcholine receptor M3 antagonist
5041,aripiprazole,Muscarinic acetylcholine receptor M4 antagonist
5045,aripiprazole,Muscarinic acetylcholine receptor M5 antagonist
5048,aripiprazole,Kappa-type opioid receptor partial agonist
5049,aripiprazole,Kappa-type opioid receptor antagonist
5053,aripiprazole,Mu-type opioid receptor antagonist
5057,aripiprazole,Delta-type opioid receptor antagonist
5065,aripiprazole,Sodium-dependent dopamine transporter antagonist
5069,aripiprazole,Sodium-dependent serotonin transporter antagonist
5072,clomipramine,Sodium-dependent serotonin transporter inhibitor
5073,clomipramine,Sodium-dependent serotonin transporter antagonist
5074,clomipramine,5-hydroxytryptamine receptor 2A inhibitor
5075,clomipramine,5-hydroxytryptamine receptor 2A antagonist
5076,clomipramine,5-hydroxytryptamine receptor 2B inhibitor
5077,clomipramine,5-hydroxytryptamine receptor 2B antagonist
5078,clomipramine,5-hydroxytryptamine receptor 2C inhibitor
5079,clomipramine,5-hydroxytryptamine receptor 2C antagonist
5080,clomipramine,Sodium-dependent noradrenaline transporter inhibitor
5081,clomipramine,Sodium-dependent noradrenaline transporter antagonist
5096,bepridil,Calmodulin inhibitor
5102,bepridil,Potassium voltage-gated channel subfamily H member 2 inhibitor
5103,bepridil,Potassium voltage-gated channel subfamily H member 2 binder
5113,dasatinib,Tyrosine-protein kinase ABL1 inhibitor
5123,dasatinib,Mast/stem cell growth factor receptor Kit inhibitor
5125,dasatinib,Platelet-derived growth factor receptor beta inhibitor
5163,darunavir,Human immunodeficiency virus type 1 protease inhibitor
5164,paliperidone,5-hydroxytryptamine receptor 2A antagonist
5165,paliperidone,5-hydroxytryptamine receptor 2A agonist
5166,paliperidone,Dopamine D2 receptor antagonist
5167,paliperidone,Dopamine D2 receptor agonist
5168,paliperidone,Histamine H1 receptor antagonist
5169,paliperidone,Histamine H1 receptor agonist
5170,paliperidone,Alpha-1A adrenergic receptor antagonist
5171,paliperidone,Alpha-1A adrenergic receptor agonist
5172,paliperidone,Alpha-1B adrenergic receptor antagonist
5173,paliperidone,Alpha-1B adrenergic receptor agonist
5174,paliperidone,Dopamine D4 receptor antagonist
5175,paliperidone,Dopamine D4 receptor agonist
5176,paliperidone,5-hydroxytryptamine receptor 1D antagonist
5177,paliperidone,5-hydroxytryptamine receptor 1D agonist
5178,paliperidone,Dopamine D3 receptor antagonist
5179,paliperidone,Dopamine D3 receptor agonist
5180,paliperidone,5-hydroxytryptamine receptor 2C antagonist
5181,paliperidone,5-hydroxytryptamine receptor 2C agonist
5182,paliperidone,Alpha-2A adrenergic receptor antagonist
5183,paliperidone,Alpha-2A adrenergic receptor agonist
5184,paliperidone,Alpha-2B adrenergic receptor antagonist
5185,paliperidone,Alpha-2B adrenergic receptor agonist
5186,paliperidone,Alpha-2C adrenergic receptor antagonist
5187,paliperidone,Alpha-2C adrenergic receptor agonist
5188,paliperidone,5-hydroxytryptamine receptor 1A antagonist
5189,paliperidone,5-hydroxytryptamine receptor 1A agonist
5190,paliperidone,Dopamine D1 receptor antagonist
5191,paliperidone,Dopamine D1 receptor agonist
5192,paliperidone,5-hydroxytryptamine receptor 7 antagonist
5193,paliperidone,5-hydroxytryptamine receptor 7 agonist
5194,sunitinib,Platelet-derived growth factor receptor beta inhibitor
5196,sunitinib,Mast/stem cell growth factor receptor Kit inhibitor
5197,sunitinib,Vascular endothelial growth factor receptor 2 inhibitor
5203,varenicline,Neuronal acetylcholine receptor subunit alpha-4 agonist
5219,nelarabine,DNA inhibitor
5221,pirbuterol,Beta-2 adrenergic receptor agonist
5222,pirbuterol,Beta-1 adrenergic receptor agonist
5223,fosamprenavir,Human immunodeficiency virus type 1 protease inhibitor
5224,fosphenytoin,Sodium channel protein type 5 subunit alpha inhibitor
5225,pancuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
5226,pancuronium,Muscarinic acetylcholine receptor M2 antagonist
5227,pancuronium,Muscarinic acetylcholine receptor M3 antagonist
5228,vecuronium,Neuronal acetylcholine receptor subunit alpha-2 antagonist
5229,cilazapril,Angiotensin-converting enzyme inhibitor
5230,amobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 potentiator
5231,amobarbital,Gamma-aminobutyric acid receptor subunit alpha-1 antagonist
5243,amobarbital,Neuronal acetylcholine receptor subunit alpha-4 antagonist
5245,amobarbital,Neuronal acetylcholine receptor subunit alpha-7 antagonist
5250,penbutolol,Beta-1 adrenergic receptor antagonist
5251,penbutolol,Beta-1 adrenergic receptor partial agonist
5252,penbutolol,Beta-2 adrenergic receptor antagonist
5253,penbutolol,Beta-2 adrenergic receptor partial agonist
5254,penbutolol,5-hydroxytryptamine receptor 1A antagonist
5255,penbutolol,5-hydroxytryptamine receptor 1A partial agonist
5256,penbutolol,5-hydroxytryptamine receptor 1B antagonist
5258,ephedrine,Sodium-dependent noradrenaline transporter agonist
5259,ephedrine,Alpha-1A adrenergic receptor agonist
5260,ephedrine,Beta-1 adrenergic receptor agonist
5261,ephedrine,Beta-2 adrenergic receptor agonist
5262,rasagiline,Amine oxidase [flavin-containing] B inhibitor
5306,bezafibrate,Peroxisome proliferator-activated receptor alpha agonist
5310,bezafibrate,Peroxisome proliferator-activated receptor gamma agonist
5312,bezafibrate,Nuclear receptor subfamily 1 group I member 2 agonist
5326,drospirenone,Androgen receptor agonist
5327,drospirenone,Androgen receptor antagonist
5329,drospirenone,Glucocorticoid receptor agonist
5332,neostigmine,Acetylcholinesterase inhibitor
5333,danazol,Estrogen receptor alpha agonist
5334,danazol,Estrogen receptor alpha inhibitor
5335,danazol,Androgen receptor agonist
5336,danazol,Androgen receptor inhibitor
5345,tiotropium,Muscarinic acetylcholine receptor M3 antagonist
5346,tiotropium,Muscarinic acetylcholine receptor M1 antagonist
5347,tiotropium,Muscarinic acetylcholine receptor M2 antagonist
5348,tiotropium,Muscarinic acetylcholine receptor M4 antagonist
5349,tiotropium,Muscarinic acetylcholine receptor M5 antagonist
5351,flunitrazepam,GABA(A) Receptor ligand
5352,flunitrazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
5353,bromazepam,GABA(A) Receptor ligand
5354,bromazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
5355,phendimetrazine,Alpha-1A adrenergic receptor agonist
5356,phendimetrazine,Sodium-dependent noradrenaline transporter agonist
5357,phendimetrazine,Alpha-1B adrenergic receptor agonist
5358,oxprenolol,Beta-1 adrenergic receptor antagonist
5359,oxprenolol,Beta-2 adrenergic receptor antagonist
5360,oxprenolol,Beta-3 adrenergic receptor antagonist
5362,solifenacin,Muscarinic acetylcholine receptor M3 antagonist
5363,solifenacin,Muscarinic acetylcholine receptor M1 antagonist
5364,solifenacin,Muscarinic acetylcholine receptor M2 antagonist
5365,solifenacin,Muscarinic acetylcholine receptor M4 antagonist
5366,solifenacin,Muscarinic acetylcholine receptor M5 antagonist
5371,molindone,Dopamine D2 receptor antagonist
5372,molindone,Dopamine D2 receptor other/unknown
5373,molindone,5-hydroxytryptamine receptor 1A antagonist
5374,molindone,5-hydroxytryptamine receptor 1A other/unknown
5375,molindone,5-hydroxytryptamine receptor 2A antagonist
5376,molindone,5-hydroxytryptamine receptor 2A other/unknown
5377,molindone,Muscarinic acetylcholine receptor M1 antagonist
5379,thiothixene,Dopamine D2 receptor antagonist
5380,thiothixene,Dopamine D1 receptor antagonist
5381,thiothixene,5-hydroxytryptamine receptor 2A antagonist
5382,zuclopenthixol,Dopamine D1 receptor antagonist
5383,zuclopenthixol,Dopamine D5 receptor antagonist
5384,zuclopenthixol,Dopamine D2 receptor antagonist
5385,zuclopenthixol,Alpha-1A adrenergic receptor antagonist
5386,zuclopenthixol,Alpha-2A adrenergic receptor antagonist
5387,zuclopenthixol,5-hydroxytryptamine receptor 2A antagonist
5388,zuclopenthixol,Histamine H1 receptor antagonist
5390,etoricoxib,Prostaglandin G/H synthase 2 inhibitor
5396,vorinostat,Histone deacetylase 2 inhibitor
5406,estriol,Estrogen receptor alpha agonist
5407,estriol,Estrogen receptor beta agonist
5410,tetrabenazine,Synaptic vesicular amine transporter inhibitor
5411,tetrabenazine,Dopamine D2 receptor inhibitor
5413,celiprolol,Beta-1 adrenergic receptor antagonist
5414,celiprolol,Beta-1 adrenergic receptor agonist
5415,celiprolol,Beta-2 adrenergic receptor antagonist
5416,celiprolol,Beta-2 adrenergic receptor agonist
5417,celiprolol,Beta-3 adrenergic receptor antagonist
5418,celiprolol,Beta-3 adrenergic receptor agonist
5419,celiprolol,Alpha-2A adrenergic receptor antagonist
5420,celiprolol,Alpha-2A adrenergic receptor agonist
5421,celiprolol,Alpha-2B adrenergic receptor antagonist
5422,celiprolol,Alpha-2B adrenergic receptor agonist
5423,celiprolol,Alpha-2C adrenergic receptor antagonist
5424,celiprolol,Alpha-2C adrenergic receptor agonist
5426,dronedarone,Alpha-1A adrenergic receptor antagonist
5427,dronedarone,Alpha-1A adrenergic receptor inhibitor
5428,dronedarone,Alpha-1B adrenergic receptor antagonist
5429,dronedarone,Alpha-1B adrenergic receptor inhibitor
5430,dronedarone,Alpha-1D adrenergic receptor antagonist
5431,dronedarone,Alpha-1D adrenergic receptor inhibitor
5432,dronedarone,Alpha-2A adrenergic receptor antagonist
5433,dronedarone,Alpha-2A adrenergic receptor inhibitor
5434,dronedarone,Alpha-2B adrenergic receptor antagonist
5435,dronedarone,Alpha-2B adrenergic receptor inhibitor
5436,dronedarone,Alpha-2C adrenergic receptor antagonist
5437,dronedarone,Alpha-2C adrenergic receptor inhibitor
5438,dronedarone,Beta-1 adrenergic receptor antagonist
5439,dronedarone,Beta-1 adrenergic receptor inhibitor
5440,dronedarone,Potassium voltage-gated channel subfamily H member 2 antagonist
5441,dronedarone,Potassium voltage-gated channel subfamily H member 2 inhibitor
5443,dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1C inhibitor
5445,dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1D inhibitor
5449,dronedarone,Voltage-dependent L-type calcium channel subunit alpha-1S inhibitor
5453,dronedarone,Voltage-dependent L-type calcium channel subunit beta-2 inhibitor
5461,dronedarone,Sodium channel protein type 5 subunit alpha inhibitor
5474,nebivolol,Beta-1 adrenergic receptor antagonist
5475,nebivolol,Beta-1 adrenergic receptor agonist
5476,nebivolol,Beta-2 adrenergic receptor antagonist
5477,nebivolol,Beta-2 adrenergic receptor agonist
5478,nebivolol,Beta-3 adrenergic receptor antagonist
5479,nebivolol,Beta-3 adrenergic receptor agonist
5480,nilotinib,Tyrosine-protein kinase ABL1 inhibitor
5482,nilotinib,Mast/stem cell growth factor receptor Kit inhibitor
5485,milnacipran,Sodium-dependent serotonin transporter inhibitor
5486,milnacipran,Sodium-dependent noradrenaline transporter inhibitor
5491,ospemifene,Estrogen receptor alpha antagonist
5492,ospemifene,Estrogen receptor alpha agonist
5493,iloperidone,5-hydroxytryptamine receptor 2A antagonist
5494,iloperidone,Dopamine D2 receptor antagonist
5495,iloperidone,Dopamine D1 receptor antagonist
5496,iloperidone,Dopamine D3 receptor antagonist
5497,iloperidone,Dopamine D4 receptor antagonist
5498,iloperidone,5-hydroxytryptamine receptor 1A antagonist
5499,iloperidone,5-hydroxytryptamine receptor 6 antagonist
5500,iloperidone,5-hydroxytryptamine receptor 7 antagonist
5501,iloperidone,Alpha-1A adrenergic receptor antagonist
5502,iloperidone,Histamine H1 receptor antagonist
5503,iloperidone,Alpha-2C adrenergic receptor antagonist
5505,indacaterol,Beta-2 adrenergic receptor agonist
5506,rotigotine,Dopamine D3 receptor agonist
5507,rotigotine,Dopamine D3 receptor antagonist
5508,rotigotine,Dopamine D4 receptor agonist
5509,rotigotine,Dopamine D4 receptor antagonist
5510,rotigotine,Dopamine D5 receptor agonist
5511,rotigotine,Dopamine D5 receptor antagonist
5512,rotigotine,Dopamine D2 receptor agonist
5513,rotigotine,Dopamine D2 receptor antagonist
5514,rotigotine,Dopamine D1 receptor agonist
5515,rotigotine,Dopamine D1 receptor antagonist
5516,rotigotine,5-hydroxytryptamine receptor 1A agonist
5517,rotigotine,5-hydroxytryptamine receptor 1A antagonist
5518,rotigotine,Alpha-2B adrenergic receptor agonist
5519,rotigotine,Alpha-2B adrenergic receptor antagonist
5525,histamine,Histamine H1 receptor agonist
5534,mianserin,Alpha-2A adrenergic receptor antagonist
5535,mianserin,Alpha-2A adrenergic receptor inhibitor
5536,mianserin,Alpha-2A adrenergic receptor binder
5537,mianserin,Alpha-2A adrenergic receptor agonist
5538,mianserin,5-hydroxytryptamine receptor 2A antagonist
5539,mianserin,5-hydroxytryptamine receptor 2A inhibitor
5540,mianserin,5-hydroxytryptamine receptor 2A binder
5541,mianserin,5-hydroxytryptamine receptor 2A agonist
5542,mianserin,5-hydroxytryptamine receptor 2C antagonist
5543,mianserin,5-hydroxytryptamine receptor 2C inhibitor
5544,mianserin,5-hydroxytryptamine receptor 2C binder
5545,mianserin,5-hydroxytryptamine receptor 2C agonist
5546,mianserin,Histamine H1 receptor antagonist
5547,mianserin,Histamine H1 receptor inhibitor
5548,mianserin,Histamine H1 receptor binder
5549,mianserin,Histamine H1 receptor agonist
5550,mianserin,Sodium-dependent noradrenaline transporter antagonist
5551,mianserin,Sodium-dependent noradrenaline transporter inhibitor
5552,mianserin,Sodium-dependent noradrenaline transporter binder
5553,mianserin,Sodium-dependent noradrenaline transporter agonist
5554,mianserin,Sodium-dependent serotonin transporter antagonist
5555,mianserin,Sodium-dependent serotonin transporter inhibitor
5556,mianserin,Sodium-dependent serotonin transporter binder
5557,mianserin,Sodium-dependent serotonin transporter agonist
5558,mianserin,Histamine H4 receptor antagonist
5560,mianserin,Histamine H4 receptor binder
5562,mianserin,5-hydroxytryptamine receptor 1A antagonist
5563,mianserin,5-hydroxytryptamine receptor 1A inhibitor
5564,mianserin,5-hydroxytryptamine receptor 1A binder
5565,mianserin,5-hydroxytryptamine receptor 1A agonist
5566,mianserin,Alpha-2C adrenergic receptor antagonist
5567,mianserin,Alpha-2C adrenergic receptor inhibitor
5569,mianserin,Alpha-2C adrenergic receptor agonist
5570,mianserin,5-hydroxytryptamine receptor 2B antagonist
5571,mianserin,5-hydroxytryptamine receptor 2B inhibitor
5572,mianserin,5-hydroxytryptamine receptor 2B binder
5573,mianserin,5-hydroxytryptamine receptor 2B agonist
5577,mianserin,5-hydroxytryptamine receptor 1F agonist
5578,mianserin,Alpha-2B adrenergic receptor antagonist
5579,mianserin,Alpha-2B adrenergic receptor inhibitor
5580,mianserin,Alpha-2B adrenergic receptor binder
5581,mianserin,Alpha-2B adrenergic receptor agonist
5582,mianserin,Dopamine D3 receptor antagonist
5583,mianserin,Dopamine D3 receptor inhibitor
5584,mianserin,Dopamine D3 receptor binder
5585,mianserin,Dopamine D3 receptor agonist
5586,mianserin,Kappa-type opioid receptor antagonist
5587,mianserin,Kappa-type opioid receptor inhibitor
5588,mianserin,Kappa-type opioid receptor binder
5589,mianserin,Kappa-type opioid receptor agonist
5590,mianserin,Sodium-dependent dopamine transporter antagonist
5591,mianserin,Sodium-dependent dopamine transporter inhibitor
5592,mianserin,Sodium-dependent dopamine transporter binder
5593,mianserin,Sodium-dependent dopamine transporter agonist
5594,mianserin,5-hydroxytryptamine receptor 7 antagonist
5595,mianserin,5-hydroxytryptamine receptor 7 inhibitor
5596,mianserin,5-hydroxytryptamine receptor 7 binder
5597,mianserin,5-hydroxytryptamine receptor 7 agonist
5598,mianserin,Dopamine D2 receptor antagonist
5599,mianserin,Dopamine D2 receptor inhibitor
5600,mianserin,Dopamine D2 receptor binder
5601,mianserin,Dopamine D2 receptor agonist
5602,mianserin,5-hydroxytryptamine receptor 6 antagonist
5603,mianserin,5-hydroxytryptamine receptor 6 inhibitor
5604,mianserin,5-hydroxytryptamine receptor 6 binder
5606,mianserin,Alpha-1 adrenergic receptors antagonist
5607,mianserin,Alpha-1 adrenergic receptors inhibitor
5608,mianserin,Alpha-1 adrenergic receptors binder
5609,mianserin,Alpha-1 adrenergic receptors agonist
5610,mianserin,D(1) dopamine receptor antagonist
5611,mianserin,D(1) dopamine receptor inhibitor
5612,mianserin,D(1) dopamine receptor binder
5613,mianserin,D(1) dopamine receptor agonist
5617,romidepsin,Histone deacetylase 2 inhibitor
5626,lasofoxifene,Estrogen receptor alpha antagonist
5627,lasofoxifene,Estrogen receptor alpha agonist
5629,lasofoxifene,Estrogen receptor beta agonist
5632,tapentadol,Mu-type opioid receptor agonist
5633,tapentadol,Mu-type opioid receptor inhibitor
5634,tapentadol,Sodium-dependent noradrenaline transporter agonist
5635,tapentadol,Sodium-dependent noradrenaline transporter inhibitor
5636,tapentadol,Kappa-type opioid receptor agonist
5637,tapentadol,Kappa-type opioid receptor inhibitor
5638,tapentadol,Delta-type opioid receptor agonist
5640,tapentadol,5-hydroxytryptamine receptor 3A agonist
5641,tapentadol,5-hydroxytryptamine receptor 3A inhibitor
5642,tapentadol,Sodium-dependent serotonin transporter agonist
5643,tapentadol,Sodium-dependent serotonin transporter inhibitor
5644,silodosin,Alpha-1A adrenergic receptor antagonist
5645,silodosin,Alpha-1D adrenergic receptor antagonist
5646,silodosin,Alpha-1B adrenergic receptor antagonist
5652,asenapine,5-hydroxytryptamine receptor 1A antagonist
5653,asenapine,5-hydroxytryptamine receptor 1B antagonist
5654,asenapine,5-hydroxytryptamine receptor 2A antagonist
5655,asenapine,5-hydroxytryptamine receptor 2B antagonist
5656,asenapine,5-hydroxytryptamine receptor 2C antagonist
5658,asenapine,5-hydroxytryptamine receptor 6 antagonist
5659,asenapine,5-hydroxytryptamine receptor 7 antagonist
5660,asenapine,Dopamine D2 receptor antagonist
5661,asenapine,Dopamine D3 receptor antagonist
5662,asenapine,Dopamine D4 receptor antagonist
5663,asenapine,Dopamine D1 receptor antagonist
5664,asenapine,Alpha-1A adrenergic receptor antagonist
5665,asenapine,Alpha-2A adrenergic receptor antagonist
5666,asenapine,Alpha-2B adrenergic receptor antagonist
5667,asenapine,Alpha-2C adrenergic receptor antagonist
5668,asenapine,Histamine H1 receptor antagonist
5669,asenapine,Histamine H2 receptor antagonist
5670,asenapine,Beta-1 adrenergic receptor antagonist
5671,asenapine,Beta-2 adrenergic receptor antagonist
5673,nalmefene,Mu-type opioid receptor antagonist
5675,nalmefene,Kappa-type opioid receptor antagonist
5676,nalmefene,Kappa-type opioid receptor partial agonist
5677,nalmefene,Delta-type opioid receptor antagonist
5679,avanafil,"cGMP-specific 3',5'-cyclic phosphodiesterase inhibitor"
5683,amisulpride,Dopamine D2 receptor antagonist
5684,amisulpride,Dopamine D2 receptor agonist
5685,amisulpride,Dopamine D3 receptor antagonist
5686,amisulpride,Dopamine D3 receptor agonist
5687,amisulpride,5-hydroxytryptamine receptor 7 antagonist
5688,amisulpride,5-hydroxytryptamine receptor 7 agonist
5689,amisulpride,5-hydroxytryptamine receptor 2A antagonist
5690,amisulpride,5-hydroxytryptamine receptor 2A agonist
5691,amisulpride,Mu-type opioid receptor antagonist
5692,amisulpride,Mu-type opioid receptor agonist
5693,amisulpride,Delta-type opioid receptor antagonist
5694,amisulpride,Delta-type opioid receptor agonist
5695,amisulpride,Kappa-type opioid receptor antagonist
5696,amisulpride,Kappa-type opioid receptor agonist
5699,bazedoxifene,Estrogen receptor alpha antagonist
5700,bazedoxifene,Estrogen receptor alpha agonist
5702,bazedoxifene,Estrogen receptor beta agonist
5707,pazopanib,Vascular endothelial growth factor receptor 2 inhibitor
5710,pazopanib,Platelet-derived growth factor receptor beta inhibitor
5711,pazopanib,Mast/stem cell growth factor receptor Kit inhibitor
5717,bosutinib,Tyrosine-protein kinase ABL1 inhibitor
5727,axitinib,Vascular endothelial growth factor receptor 2 inhibitor
5730,vilazodone,Sodium-dependent serotonin transporter inhibitor
5731,vilazodone,Sodium-dependent serotonin transporter agonist
5732,vilazodone,5-hydroxytryptamine receptor 1A inhibitor
5733,vilazodone,5-hydroxytryptamine receptor 1A agonist
5734,betahistine,Histamine H1 receptor agonist
5735,betahistine,Histamine H1 receptor antagonist
5739,desvenlafaxine,Sodium-dependent noradrenaline transporter inhibitor
5740,desvenlafaxine,Sodium-dependent serotonin transporter inhibitor
5741,desvenlafaxine,Sodium-dependent dopamine transporter inhibitor
5742,fesoterodine,Muscarinic acetylcholine receptor M3 antagonist
5743,fesoterodine,Muscarinic acetylcholine receptor M4 antagonist
5744,fesoterodine,Muscarinic acetylcholine receptor M1 antagonist
5745,fesoterodine,Muscarinic acetylcholine receptor M2 antagonist
5746,fesoterodine,Muscarinic acetylcholine receptor M5 antagonist
5747,methacholine,Muscarinic acetylcholine receptor M3 agonist
5749,methacholine,Muscarinic acetylcholine receptor M1 agonist
5770,pralatrexate,Thymidylate synthase inhibitor
5773,parecoxib,Prostaglandin G/H synthase 2 inhibitor
5775,lurasidone,Dopamine D2 receptor antagonist
5776,lurasidone,5-hydroxytryptamine receptor 2A antagonist
5777,lurasidone,5-hydroxytryptamine receptor 7 antagonist
5778,lurasidone,5-hydroxytryptamine receptor 1A antagonist
5779,lurasidone,Alpha-2C adrenergic receptor antagonist
5780,lurasidone,Alpha-2A adrenergic receptor antagonist
5797,mirabegron,Beta-3 adrenergic receptor agonist
5798,mirabegron,Beta-1 adrenergic receptor agonist
5800,regorafenib,Vascular endothelial growth factor receptor 2 inhibitor
5802,regorafenib,Mast/stem cell growth factor receptor Kit inhibitor
5804,regorafenib,Platelet-derived growth factor receptor beta inhibitor
5815,regorafenib,Tyrosine-protein kinase ABL1 inhibitor
5817,aclidinium,Muscarinic acetylcholine receptor M1 antagonist
5818,aclidinium,Muscarinic acetylcholine receptor M2 antagonist
5819,aclidinium,Muscarinic acetylcholine receptor M3 antagonist
5820,aclidinium,Muscarinic acetylcholine receptor M4 antagonist
5821,aclidinium,Muscarinic acetylcholine receptor M5 antagonist
5823,ponatinib,Tyrosine-protein kinase ABL1 inhibitor
5825,ponatinib,Mast/stem cell growth factor receptor Kit inhibitor
5836,ponatinib,Vascular endothelial growth factor receptor 2 inhibitor
5840,pomalidomide,Prostaglandin G/H synthase 2 inhibitor
5865,tibolone,Estrogen receptor alpha antagonist
5866,tibolone,Estrogen receptor alpha agonist
5867,umeclidinium,Muscarinic acetylcholine receptor M1 antagonist
5868,umeclidinium,Muscarinic acetylcholine receptor M2 antagonist
5869,umeclidinium,Muscarinic acetylcholine receptor M3 antagonist
5870,umeclidinium,Muscarinic acetylcholine receptor M4 antagonist
5871,umeclidinium,Muscarinic acetylcholine receptor M5 antagonist
5875,homatropine,Muscarinic acetylcholine receptor M1 antagonist
5876,homatropine,Muscarinic acetylcholine receptor M2 antagonist
5877,homatropine,Muscarinic acetylcholine receptor M3 antagonist
5878,homatropine,Muscarinic acetylcholine receptor M4 antagonist
5879,homatropine,Muscarinic acetylcholine receptor M5 antagonist
5881,tropisetron,5-hydroxytryptamine receptor 3A antagonist
5882,lormetazepam,GABA(A) Receptor ligand
5883,lormetazepam,GABA(A) Receptor Benzodiazepine Binding Site ligand
5884,candesartan,Type-1 angiotensin II receptor antagonist
